{"search_session":{},"preferences":{"l":"en","queryLanguage":"en"},"patentId":"US_8753611_B2","frontPageModel":{"patentViewModel":{"ref":{"entityRefId":"080-202-844-883-171","entityRefType":"PATENT"},"entityMetadata":{"linkedIds":{"empty":true},"tags":[],"collections":[{"id":22757,"type":"PATENT","title":"Citing Cornell Univ publications","description":"Patent documents citing scholarly work of Cornell Univ","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":60392,"tags":[],"user":{"id":233682368,"username":"tech","firstName":"The Lens","lastName":"Team","created":"2017-08-06T20:11:49.000Z","displayName":"The Lens Team","profilePictureKey":"lens/users/15eac2a0-031d-4923-92cb-a162e1cb2bbb/profile-picture","preferences":"{\"beta\":true}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2017-08-07T04:53:01Z","updated":"2017-08-07T04:53:01Z","lastEventDate":"2017-08-07T04:53:01Z"},{"id":22773,"type":"PATENT","title":"Citing Univ Washington publications","description":"Patent documents citing scholarly work of Univ Washington","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":75126,"tags":[],"user":{"id":233682368,"username":"tech","firstName":"The Lens","lastName":"Team","created":"2017-08-06T20:11:49.000Z","displayName":"The Lens Team","profilePictureKey":"lens/users/15eac2a0-031d-4923-92cb-a162e1cb2bbb/profile-picture","preferences":"{\"beta\":true}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2017-08-07T04:58:47Z","updated":"2017-08-07T04:58:47Z","lastEventDate":"2017-08-07T04:58:47Z"},{"id":22793,"type":"PATENT","title":"Citing Univ Wisconsin publications","description":"Patent documents citing scholarly work of Univ Wisconsin","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":57249,"tags":[],"user":{"id":233682368,"username":"tech","firstName":"The Lens","lastName":"Team","created":"2017-08-06T20:11:49.000Z","displayName":"The Lens Team","profilePictureKey":"lens/users/15eac2a0-031d-4923-92cb-a162e1cb2bbb/profile-picture","preferences":"{\"beta\":true}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2017-08-07T05:07:38Z","updated":"2017-08-07T05:07:38Z","lastEventDate":"2017-08-07T05:07:38Z"},{"id":22848,"type":"PATENT","title":"Citing Stanford Univ publications","description":"Patent documents citing scholarly work of Stanford Univ","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":108345,"tags":[],"user":{"id":233682368,"username":"tech","firstName":"The Lens","lastName":"Team","created":"2017-08-06T20:11:49.000Z","displayName":"The Lens Team","profilePictureKey":"lens/users/15eac2a0-031d-4923-92cb-a162e1cb2bbb/profile-picture","preferences":"{\"beta\":true}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2017-08-07T05:31:21Z","updated":"2017-08-07T05:31:21Z","lastEventDate":"2017-08-07T05:31:21Z"},{"id":22859,"type":"PATENT","title":"Citing Harvard Univ publications","description":"Patent documents citing scholarly work of Harvard Univ","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":175224,"tags":[],"user":{"id":233682368,"username":"tech","firstName":"The Lens","lastName":"Team","created":"2017-08-06T20:11:49.000Z","displayName":"The Lens Team","profilePictureKey":"lens/users/15eac2a0-031d-4923-92cb-a162e1cb2bbb/profile-picture","preferences":"{\"beta\":true}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2017-08-07T05:37:44Z","updated":"2017-08-07T05:37:44Z","lastEventDate":"2017-08-07T05:37:44Z"},{"id":22872,"type":"PATENT","title":"Citing Free Univ Berlin publications","description":"Patent documents citing scholarly work of Free Univ Berlin","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":28928,"tags":[],"user":{"id":233682368,"username":"tech","firstName":"The Lens","lastName":"Team","created":"2017-08-06T20:11:49.000Z","displayName":"The Lens Team","profilePictureKey":"lens/users/15eac2a0-031d-4923-92cb-a162e1cb2bbb/profile-picture","preferences":"{\"beta\":true}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2017-08-07T05:44:55Z","updated":"2017-08-07T05:44:55Z","lastEventDate":"2017-08-07T05:44:55Z"},{"id":22904,"type":"PATENT","title":"Citing Univ Utah publications","description":"Patent documents citing scholarly work of Univ Utah","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":31415,"tags":[],"user":{"id":233682368,"username":"tech","firstName":"The Lens","lastName":"Team","created":"2017-08-06T20:11:49.000Z","displayName":"The Lens Team","profilePictureKey":"lens/users/15eac2a0-031d-4923-92cb-a162e1cb2bbb/profile-picture","preferences":"{\"beta\":true}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2017-08-07T05:58:45Z","updated":"2017-08-07T05:58:45Z","lastEventDate":"2017-08-07T05:58:45Z"},{"id":182293,"type":"PATENT","title":"BIOFARMA_gral","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":11536,"tags":[],"user":{"id":354789823,"username":"neburevilo","firstName":"","lastName":"","created":"2020-05-27T12:14:20.000Z","displayName":"neburevilo","preferences":"{\"usage\":\"public\"}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2020-06-29T14:12:34Z","updated":"2020-06-29T14:13:08Z","lastEventDate":"2020-06-29T14:13:08Z"},{"id":185263,"type":"PATENT","title":"Functional food obesity","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":50000,"tags":[],"user":{"id":331464959,"username":"jonamg","firstName":"","lastName":"","created":"2019-10-14T09:28:40.000Z","displayName":"jonamg","preferences":"{}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":true,"savedQueries":[],"created":"2020-11-10T12:01:24Z","updated":"2020-11-10T12:06:39Z","lastEventDate":"2020-11-10T12:06:39Z"},{"id":196611,"type":"PATENT","title":"Materiales para administración de fármacos","description":"patentes sobre la administración de fármacos por medio de nuevos materiales.","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":50000,"tags":[],"user":{"id":429050781,"username":"Anggie_08","firstName":"","lastName":"","created":"2021-11-13T14:58:46.000Z","displayName":"Anggie_08","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":true,"savedQueries":[],"created":"2021-11-13T15:33:52Z","updated":"2021-11-13T15:35:16Z","lastEventDate":"2021-11-13T15:35:16Z"},{"id":198781,"type":"PATENT","title":"Turmeric patents granted as of 2-7-22","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":16373,"tags":[],"user":{"id":415880293,"username":"KCI","firstName":"","lastName":"","created":"2021-08-12T19:15:49.000Z","displayName":"KCI","preferences":"{\"usage\":\"public\"}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":true,"savedQueries":[],"created":"2022-02-08T03:33:18Z","updated":"2024-03-28T01:59:01Z","lastEventDate":"2024-03-28T01:59:01Z"}],"notes":[],"inventorships":[],"privateCollections":[],"publicCollections":[{"id":22757,"type":"PATENT","title":"Citing Cornell Univ publications","description":"Patent documents citing scholarly work of Cornell Univ","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":60392,"tags":[],"user":{"id":233682368,"username":"tech","firstName":"The Lens","lastName":"Team","created":"2017-08-06T20:11:49.000Z","displayName":"The Lens Team","profilePictureKey":"lens/users/15eac2a0-031d-4923-92cb-a162e1cb2bbb/profile-picture","preferences":"{\"beta\":true}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2017-08-07T04:53:01Z","updated":"2017-08-07T04:53:01Z","lastEventDate":"2017-08-07T04:53:01Z"},{"id":22773,"type":"PATENT","title":"Citing Univ Washington publications","description":"Patent documents citing scholarly work of Univ Washington","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":75126,"tags":[],"user":{"id":233682368,"username":"tech","firstName":"The Lens","lastName":"Team","created":"2017-08-06T20:11:49.000Z","displayName":"The Lens Team","profilePictureKey":"lens/users/15eac2a0-031d-4923-92cb-a162e1cb2bbb/profile-picture","preferences":"{\"beta\":true}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2017-08-07T04:58:47Z","updated":"2017-08-07T04:58:47Z","lastEventDate":"2017-08-07T04:58:47Z"},{"id":22793,"type":"PATENT","title":"Citing Univ Wisconsin publications","description":"Patent documents citing scholarly work of Univ Wisconsin","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":57249,"tags":[],"user":{"id":233682368,"username":"tech","firstName":"The Lens","lastName":"Team","created":"2017-08-06T20:11:49.000Z","displayName":"The Lens Team","profilePictureKey":"lens/users/15eac2a0-031d-4923-92cb-a162e1cb2bbb/profile-picture","preferences":"{\"beta\":true}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2017-08-07T05:07:38Z","updated":"2017-08-07T05:07:38Z","lastEventDate":"2017-08-07T05:07:38Z"},{"id":22848,"type":"PATENT","title":"Citing Stanford Univ publications","description":"Patent documents citing scholarly work of Stanford Univ","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":108345,"tags":[],"user":{"id":233682368,"username":"tech","firstName":"The Lens","lastName":"Team","created":"2017-08-06T20:11:49.000Z","displayName":"The Lens Team","profilePictureKey":"lens/users/15eac2a0-031d-4923-92cb-a162e1cb2bbb/profile-picture","preferences":"{\"beta\":true}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2017-08-07T05:31:21Z","updated":"2017-08-07T05:31:21Z","lastEventDate":"2017-08-07T05:31:21Z"},{"id":22859,"type":"PATENT","title":"Citing Harvard Univ publications","description":"Patent documents citing scholarly work of Harvard Univ","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":175224,"tags":[],"user":{"id":233682368,"username":"tech","firstName":"The Lens","lastName":"Team","created":"2017-08-06T20:11:49.000Z","displayName":"The Lens Team","profilePictureKey":"lens/users/15eac2a0-031d-4923-92cb-a162e1cb2bbb/profile-picture","preferences":"{\"beta\":true}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2017-08-07T05:37:44Z","updated":"2017-08-07T05:37:44Z","lastEventDate":"2017-08-07T05:37:44Z"},{"id":22872,"type":"PATENT","title":"Citing Free Univ Berlin publications","description":"Patent documents citing scholarly work of Free Univ Berlin","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":28928,"tags":[],"user":{"id":233682368,"username":"tech","firstName":"The Lens","lastName":"Team","created":"2017-08-06T20:11:49.000Z","displayName":"The Lens Team","profilePictureKey":"lens/users/15eac2a0-031d-4923-92cb-a162e1cb2bbb/profile-picture","preferences":"{\"beta\":true}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2017-08-07T05:44:55Z","updated":"2017-08-07T05:44:55Z","lastEventDate":"2017-08-07T05:44:55Z"},{"id":22904,"type":"PATENT","title":"Citing Univ Utah publications","description":"Patent documents citing scholarly work of Univ Utah","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":31415,"tags":[],"user":{"id":233682368,"username":"tech","firstName":"The Lens","lastName":"Team","created":"2017-08-06T20:11:49.000Z","displayName":"The Lens Team","profilePictureKey":"lens/users/15eac2a0-031d-4923-92cb-a162e1cb2bbb/profile-picture","preferences":"{\"beta\":true}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2017-08-07T05:58:45Z","updated":"2017-08-07T05:58:45Z","lastEventDate":"2017-08-07T05:58:45Z"},{"id":182293,"type":"PATENT","title":"BIOFARMA_gral","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":11536,"tags":[],"user":{"id":354789823,"username":"neburevilo","firstName":"","lastName":"","created":"2020-05-27T12:14:20.000Z","displayName":"neburevilo","preferences":"{\"usage\":\"public\"}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2020-06-29T14:12:34Z","updated":"2020-06-29T14:13:08Z","lastEventDate":"2020-06-29T14:13:08Z"},{"id":185263,"type":"PATENT","title":"Functional food obesity","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":50000,"tags":[],"user":{"id":331464959,"username":"jonamg","firstName":"","lastName":"","created":"2019-10-14T09:28:40.000Z","displayName":"jonamg","preferences":"{}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":true,"savedQueries":[],"created":"2020-11-10T12:01:24Z","updated":"2020-11-10T12:06:39Z","lastEventDate":"2020-11-10T12:06:39Z"},{"id":196611,"type":"PATENT","title":"Materiales para administración de fármacos","description":"patentes sobre la administración de fármacos por medio de nuevos materiales.","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":50000,"tags":[],"user":{"id":429050781,"username":"Anggie_08","firstName":"","lastName":"","created":"2021-11-13T14:58:46.000Z","displayName":"Anggie_08","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":true,"savedQueries":[],"created":"2021-11-13T15:33:52Z","updated":"2021-11-13T15:35:16Z","lastEventDate":"2021-11-13T15:35:16Z"},{"id":198781,"type":"PATENT","title":"Turmeric patents granted as of 2-7-22","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":16373,"tags":[],"user":{"id":415880293,"username":"KCI","firstName":"","lastName":"","created":"2021-08-12T19:15:49.000Z","displayName":"KCI","preferences":"{\"usage\":\"public\"}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":true,"savedQueries":[],"created":"2022-02-08T03:33:18Z","updated":"2024-03-28T01:59:01Z","lastEventDate":"2024-03-28T01:59:01Z"}],"privateNotes":[],"landscapeCollections":[],"landscapeNotes":[]},"document":{"record_lens_id":"080-202-844-883-171","lens_id":["080-202-844-883-171","032-889-557-155-369"],"doc_key":"US_8753611_B2_20140617","created":"2016-01-15T08:28:34.436","docdb_id":419022548,"lens_internal":{"earliest_lens_id_created_time":"2016-01-15T08:28:34.436","last_modified":"2024-03-25T03:00:45.505","legacy_pub_key":"US_8753611_B2","has_doc_lang":true,"has_biblio_lang":true,"has_all_title_lang":true,"has_all_abstract_lang":true,"has_all_claims_lang":true,"has_description_lang":true},"jurisdiction":"US","doc_number":"8753611","kind":"B2","date_published":"2014-06-17","year_published":2014,"ids":["US_8753611_B2","080-202-844-883-171","032-889-557-155-369","US_8753611_B2_20140617","US","8753611","B2","US8753611B2","US8753611","8753611B2"],"lang":"en","publication_type":"GRANTED_PATENT","application_reference":{"jurisdiction":"US","doc_number":"201113099003","kind":"A","date":"2011-05-02"},"priority_claim":[{"jurisdiction":"US","doc_number":"201113099003","kind":"A","date":"2011-05-02"},{"jurisdiction":"US","doc_number":"42947509","kind":"A","date":"2009-04-24"},{"jurisdiction":"US","doc_number":"66169300","kind":"A","date":"2000-09-14"},{"jurisdiction":"US","doc_number":"32781499","kind":"A","date":"1999-06-08"},{"jurisdiction":"US","doc_number":"27742499","kind":"A","date":"1999-03-26"},{"jurisdiction":"US","doc_number":"7965298","kind":"P","date":"1998-03-27"}],"priority_claim.source":"DOCDB","earliest_priority_claim_date":"1998-03-27","title":{"en":[{"text":"Sublingual buccal effervescent","lang":"en","source":"DOCDB","data_format":"DOCDBA"}]},"title_lang":["en"],"has_title":true,"applicant":[{"name":"EICHMAN JONATHAN D","residence":"US","sequence":1,"app_type":"applicant"},{"name":"HONTZ JOHN","residence":"US","sequence":2,"app_type":"applicant"},{"name":"KHANKARI RAJENDRA K","residence":"US","sequence":3,"app_type":"applicant"},{"name":"PATHER SATHASIVAN INDIRAN","residence":"US","sequence":4,"app_type":"applicant"},{"name":"ROBINSON JOSEPH R","residence":"US","sequence":5,"app_type":"applicant"},{"name":"CEPHALON INC","residence":"US","sequence":6,"app_type":"applicant"}],"applicant_count":6,"has_applicant":true,"inventor":[{"name":"EICHMAN JONATHAN D","residence":"US","sequence":1},{"name":"HONTZ JOHN","residence":"US","sequence":2},{"name":"KHANKARI RAJENDRA K","residence":"US","sequence":3},{"name":"PATHER SATHASIVAN INDIRAN","residence":"US","sequence":4},{"name":"ROBINSON JOSEPH R","residence":"US","sequence":5}],"inventor_count":5,"has_inventor":true,"agent":[],"agent_count":0,"has_agent":false,"owner":[{"name":"CEPHALON INC","address":"41 MOORES ROAD, PO BOX 4011, FRAZER, PENNSYLVANIA, 19355","sequence":1,"recorded_date":"2011-06-15","execution_date":"2011-06-14","is_current_owner":true}],"owner_count":1,"owner_all":[{"name":"CEPHALON INC","address":"41 MOORES ROAD, PO BOX 4011, FRAZER, PENNSYLVANIA, 19355","sequence":1,"recorded_date":"2011-06-15","execution_date":"2011-06-14","is_current_owner":true}],"owner_all_count":1,"has_owner":true,"primary_examiner":{"name":"Sreeni Padmanabhan","department":"1627"},"assistant_examiner":{"name":"Uma Ramachandran"},"has_examiner":true,"class_ipcr":[{"symbol":"A01N25/02","version_indicator":"2006-01-01","class_symbol_position":"F","class_value":"I","action_date":"2014-06-17","class_status":"B","class_data_source":"H","generating_office":"US","sequence":1},{"symbol":"A61F13/00","version_indicator":"2006-01-01","class_symbol_position":"L","class_value":"I","action_date":"2014-06-17","class_status":"B","class_data_source":"H","generating_office":"US","sequence":2},{"symbol":"A61K9/00","version_indicator":"2006-01-01","class_value":"I","action_date":"2005-10-08","class_status":"R","class_data_source":"M","generating_office":"EP","sequence":3},{"symbol":"A61K9/12","version_indicator":"2006-01-01","class_symbol_position":"L","class_value":"I","action_date":"2014-06-17","class_status":"B","class_data_source":"H","generating_office":"US","sequence":4},{"symbol":"A61K9/20","version_indicator":"2006-01-01","class_symbol_position":"L","class_value":"I","action_date":"2014-06-17","class_status":"B","class_data_source":"H","generating_office":"US","sequence":5},{"symbol":"A61K9/46","version_indicator":"2006-01-01","class_symbol_position":"L","class_value":"I","action_date":"2014-06-17","class_status":"B","class_data_source":"H","generating_office":"US","sequence":6},{"symbol":"A61K31/4468","version_indicator":"2006-01-01","class_value":"I","action_date":"2005-10-08","class_status":"R","class_data_source":"M","generating_office":"EP","sequence":7},{"symbol":"A61K31/5415","version_indicator":"2006-01-01","class_value":"I","action_date":"2005-10-08","class_status":"R","class_data_source":"M","generating_office":"EP","sequence":8}],"class_ipcr.first_symbol":"A01N25/02","class_ipcr.later_symbol":["A61F13/00","A61K9/00","A61K9/12","A61K9/20","A61K9/46","A61K31/4468","A61K31/5415"],"class_ipcr.inv_symbol":["A01N25/02","A61F13/00","A61K9/00","A61K9/12","A61K9/20","A61K9/46","A61K31/4468","A61K31/5415"],"class_ipcr.add_symbol":[],"class_ipcr.source":"DOCDB","class_cpc":[{"symbol":"A61K9/0007","version_indicator":"2013-01-01","class_symbol_position":"L","class_value":"I","action_date":"2013-01-01","class_status":"B","class_data_source":"H","generating_office":"EP","sequence":1},{"symbol":"A61K9/0056","version_indicator":"2013-01-01","class_symbol_position":"L","class_value":"I","action_date":"2013-01-01","class_status":"B","class_data_source":"H","generating_office":"EP","sequence":2},{"symbol":"A61K9/006","version_indicator":"2013-01-01","class_symbol_position":"L","class_value":"I","action_date":"2013-01-01","class_status":"B","class_data_source":"H","generating_office":"EP","sequence":3},{"symbol":"A61K31/4468","version_indicator":"2013-01-01","class_symbol_position":"F","class_value":"I","action_date":"2013-01-01","class_status":"B","class_data_source":"H","generating_office":"EP","sequence":4},{"symbol":"A61K31/5415","version_indicator":"2013-01-01","class_symbol_position":"L","class_value":"I","action_date":"2013-01-01","class_status":"B","class_data_source":"H","generating_office":"EP","sequence":5},{"symbol":"A61P25/04","version_indicator":"2018-01-01","class_symbol_position":"L","class_value":"I","action_date":"2020-03-23","class_status":"B","class_data_source":"H","generating_office":"EP","sequence":6},{"symbol":"A61K31/4468","version_indicator":"2013-01-01","class_symbol_position":"F","class_value":"I","action_date":"2019-08-22","class_status":"B","class_data_source":"H","generating_office":"US","sequence":7},{"symbol":"A61K9/0056","version_indicator":"2013-01-01","class_symbol_position":"L","class_value":"I","action_date":"2019-10-11","class_status":"B","class_data_source":"H","generating_office":"US","sequence":8},{"symbol":"A61K31/5415","version_indicator":"2013-01-01","class_symbol_position":"L","class_value":"I","action_date":"2019-10-11","class_status":"B","class_data_source":"H","generating_office":"US","sequence":9},{"symbol":"A61K9/0007","version_indicator":"2013-01-01","class_symbol_position":"L","class_value":"I","action_date":"2019-10-11","class_status":"B","class_data_source":"H","generating_office":"US","sequence":10},{"symbol":"A61K9/006","version_indicator":"2013-01-01","class_symbol_position":"L","class_value":"I","action_date":"2019-10-11","class_status":"B","class_data_source":"H","generating_office":"US","sequence":11}],"class_cpc_cset":[],"class_cpc.first_symbol":"A61K31/4468","class_cpc.later_symbol":["A61K9/0007","A61K9/0056","A61K9/006","A61K31/5415","A61P25/04","A61K9/0056","A61K31/5415","A61K9/0007","A61K9/006"],"class_cpc.inv_symbol":["A61K9/0007","A61K9/0056","A61K9/006","A61K31/4468","A61K31/5415","A61P25/04","A61K31/4468","A61K9/0056","A61K31/5415","A61K9/0007","A61K9/006"],"class_cpc.add_symbol":[],"class_cpc.source":"DOCDB","class_national":[{"symbol":"424/43","symbol_position":"F"},{"symbol":"424/44","symbol_position":"L"},{"symbol":"424/434","symbol_position":"L"},{"symbol":"424/466","symbol_position":"L"},{"symbol":"424/464","symbol_position":"L"}],"class_national.first_symbol":"424/43","class_national.later_symbol":["424/44","424/434","424/466","424/464"],"class_national.source":"DOCDB","reference_cited":[{"patent":{"num":1,"document_id":{"jurisdiction":"US","doc_number":"5223264","kind":"A","date":"1993-06-29","name":"WEHLING FRED [US], et al"},"lens_id":"166-301-801-559-795","category":[],"us_category":[],"cited_phase":"SEA","rel_claims":[],"sequence":1}},{"patent":{"num":2,"document_id":{"jurisdiction":"US","doc_number":"6071539","kind":"A","date":"2000-06-06","name":"ROBINSON JOSEPH R [US], et al"},"lens_id":"127-147-898-496-817","category":[],"us_category":[],"cited_phase":"SEA","rel_claims":[],"sequence":2}},{"patent":{"num":3,"document_id":{"jurisdiction":"WO","doc_number":"9104757","kind":"A1","date":"1991-04-18","name":"CIMA LABS INC [US]"},"lens_id":"066-768-075-282-413","category":[],"us_category":[],"cited_phase":"SEA","rel_claims":[],"sequence":3}},{"patent":{"num":1,"document_id":{"jurisdiction":"US","doc_number":"1262888","kind":"A","date":"1918-04-16","name":"WESTLAKE ALBERT [US]"},"lens_id":"161-763-778-185-768","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":1}},{"patent":{"num":2,"document_id":{"jurisdiction":"US","doc_number":"2887437","kind":"A","date":"1959-05-19","name":"OSCAR KLIOZE, et al"},"lens_id":"088-790-999-161-661","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":2}},{"patent":{"num":3,"document_id":{"jurisdiction":"US","doc_number":"3042531","kind":"A","date":"1962-07-03","name":"LEAL BERNARDINE J, et al"},"lens_id":"195-988-626-127-906","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":3}},{"patent":{"num":4,"document_id":{"jurisdiction":"US","doc_number":"3131123","kind":"A","date":"1964-04-28","name":"MASQUELIER JACK A"},"lens_id":"064-796-190-560-592","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":4}},{"patent":{"num":5,"document_id":{"jurisdiction":"US","doc_number":"3577490","kind":"A","date":"1971-05-04","name":"WELSH THOMAS LAURENCE, et al"},"lens_id":"115-312-751-584-944","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":5}},{"patent":{"num":6,"document_id":{"jurisdiction":"US","doc_number":"3888976","kind":"A","date":"1975-06-10","name":"MLKVY WILLIAM P, et al"},"lens_id":"125-427-430-483-387","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":6}},{"patent":{"num":7,"document_id":{"jurisdiction":"US","doc_number":"3961041","kind":"A","date":"1976-06-01","name":"NISHIMURA KENJI, et al"},"lens_id":"190-086-442-341-022","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":7}},{"patent":{"num":8,"document_id":{"jurisdiction":"US","doc_number":"3962417","kind":"A","date":"1976-06-08","name":"HOWELL CHARLES J"},"lens_id":"167-908-598-389-598","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":8}},{"patent":{"num":9,"document_id":{"jurisdiction":"US","doc_number":"3972995","kind":"A","date":"1976-08-03","name":"TSUK ANDREW G, et al"},"lens_id":"021-529-652-130-372","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":9}},{"patent":{"num":10,"document_id":{"jurisdiction":"US","doc_number":"4147768","kind":"A","date":"1979-04-03","name":"SHAFFER RICHARD D, et al"},"lens_id":"148-854-122-379-749","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":10}},{"patent":{"num":11,"document_id":{"jurisdiction":"US","doc_number":"4187286","kind":"A","date":"1980-02-05","name":"MARCUS BERTRAM J [US]"},"lens_id":"083-579-724-651-471","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":11}},{"patent":{"num":12,"document_id":{"jurisdiction":"US","doc_number":"4289751","kind":"A","date":"1981-09-15","name":"WINDHEUSER JOHN J"},"lens_id":"018-041-935-596-837","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":12}},{"patent":{"num":13,"document_id":{"jurisdiction":"US","doc_number":"4370160","kind":"A","date":"1983-01-25","name":"ZIEMELIS MARIS J"},"lens_id":"079-615-724-163-479","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":13}},{"patent":{"num":14,"document_id":{"jurisdiction":"US","doc_number":"4443428","kind":"A","date":"1984-04-17","name":"OSHLACK BENJAMIN [US], et al"},"lens_id":"199-657-193-500-769","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":14}},{"patent":{"num":15,"document_id":{"jurisdiction":"US","doc_number":"4493848","kind":"A","date":"1985-01-15","name":"LAHANN THOMAS R [US], et al"},"lens_id":"152-887-992-417-986","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":15}},{"patent":{"num":16,"document_id":{"jurisdiction":"US","doc_number":"4503031","kind":"A","date":"1985-03-05","name":"GLASSMAN JACOB A [US]"},"lens_id":"068-590-219-906-422","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":16}},{"patent":{"num":17,"document_id":{"jurisdiction":"US","doc_number":"4599342","kind":"A","date":"1986-07-08","name":"LAHANN THOMAS R [US]"},"lens_id":"002-273-152-941-747","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":17}},{"patent":{"num":18,"document_id":{"jurisdiction":"US","doc_number":"4613497","kind":"A","date":"1986-09-23","name":"CHAVKIN LEONARD [US]"},"lens_id":"123-170-256-408-504","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":18}},{"patent":{"num":19,"document_id":{"jurisdiction":"US","doc_number":"4639368","kind":"A","date":"1987-01-27","name":"NIAZI SARFARAZ [US], et al"},"lens_id":"062-163-677-149-989","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":19}},{"patent":{"num":20,"document_id":{"jurisdiction":"US","doc_number":"4671953","kind":"A","date":"1987-06-09","name":"STANLEY THEODORE H [US], et al"},"lens_id":"025-099-720-986-390","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":20}},{"patent":{"num":21,"document_id":{"jurisdiction":"US","doc_number":"4687662","kind":"A","date":"1987-08-18","name":"SCHOBEL ALEXANDER M [US]"},"lens_id":"191-046-926-441-011","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":21}},{"patent":{"num":22,"document_id":{"jurisdiction":"US","doc_number":"4689218","kind":"A","date":"1987-08-25","name":"GAZZANIGA ANNIBALE [IT], et al"},"lens_id":"040-302-643-070-999","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":22}},{"patent":{"num":23,"document_id":{"jurisdiction":"US","doc_number":"4717723","kind":"A","date":"1988-01-05","name":"SUGDEN KEITH [GB]"},"lens_id":"013-136-272-621-682","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":23}},{"patent":{"num":24,"document_id":{"jurisdiction":"US","doc_number":"4725427","kind":"A","date":"1988-02-16","name":"ASHMEAD H DEWAYNE [US], et al"},"lens_id":"062-749-177-990-446","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":24}},{"patent":{"num":25,"document_id":{"jurisdiction":"US","doc_number":"4753792","kind":"A","date":"1988-06-28","name":"ABERG TORWALD [SE]"},"lens_id":"169-826-127-820-197","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":25}},{"patent":{"num":26,"document_id":{"jurisdiction":"US","doc_number":"4756710","kind":"A","date":"1988-07-12","name":"BONDI JOSEPH V [US], et al"},"lens_id":"187-577-282-590-027","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":26}},{"patent":{"num":27,"document_id":{"jurisdiction":"US","doc_number":"4853211","kind":"A","date":"1989-08-01","name":"KUROBE TOSHIO [JP], et al"},"lens_id":"183-039-590-188-052","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":27}},{"patent":{"num":28,"document_id":{"jurisdiction":"US","doc_number":"4863737","kind":"A","date":"1989-09-05","name":"STANLEY THEODORE H [US], et al"},"lens_id":"075-354-290-637-754","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":28}},{"patent":{"num":29,"document_id":{"jurisdiction":"US","doc_number":"4876039","kind":"A","date":"1989-10-24","name":"LO PETER Y K [US], et al"},"lens_id":"028-809-551-886-569","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":29}},{"patent":{"num":30,"document_id":{"jurisdiction":"US","doc_number":"4940588","kind":"A","date":"1990-07-10","name":"SPARKS RANDALL T [US], et al"},"lens_id":"043-374-999-967-299","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":30}},{"patent":{"num":31,"document_id":{"jurisdiction":"US","doc_number":"5002771","kind":"A","date":"1991-03-26","name":"PURKAYSTHA ABDUR R [US], et al"},"lens_id":"171-956-720-636-777","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":31}},{"patent":{"num":32,"document_id":{"jurisdiction":"US","doc_number":"5004601","kind":"A","date":"1991-04-02","name":"SNIPES WALLACE C [US]"},"lens_id":"179-740-968-098-317","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":32}},{"patent":{"num":33,"document_id":{"jurisdiction":"US","doc_number":"5028411","kind":"A","date":"1991-07-02","name":"CALLINGHAM BRIAN A [GB], et al"},"lens_id":"068-498-018-596-112","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":33}},{"patent":{"num":34,"document_id":{"jurisdiction":"US","doc_number":"5053396","kind":"A","date":"1991-10-01","name":"BLASS DAVID H [GB]"},"lens_id":"102-497-884-996-071","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":34}},{"patent":{"num":35,"document_id":{"jurisdiction":"US","doc_number":"5055306","kind":"A","date":"1991-10-08","name":"BARRY BRIAN W [GB], et al"},"lens_id":"177-828-027-492-201","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":35}},{"patent":{"num":36,"document_id":{"jurisdiction":"US","doc_number":"5073374","kind":"A","date":"1991-12-17","name":"MCCARTY JOHN A [US]"},"lens_id":"007-758-396-762-072","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":36}},{"patent":{"num":37,"document_id":{"jurisdiction":"US","doc_number":"5102665","kind":"A","date":"1992-04-07","name":"SCHAEFFER ALAIN E E [FR]"},"lens_id":"156-207-966-783-038","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":37}},{"patent":{"num":38,"document_id":{"jurisdiction":"US","doc_number":"5102666","kind":"A","date":"1992-04-07","name":"ACHARYA RAMESH N [US]"},"lens_id":"013-559-569-682-413","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":38}},{"patent":{"num":39,"document_id":{"jurisdiction":"US","doc_number":"5135752","kind":"A","date":"1992-08-04","name":"SNIPES WALLACE C [US]"},"lens_id":"110-296-282-593-418","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":39}},{"patent":{"num":40,"document_id":{"jurisdiction":"US","doc_number":"5178878","kind":"A","date":"1993-01-12","name":"WEHLING FRED [US], et al"},"lens_id":"154-171-940-400-727","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":40}},{"patent":{"num":41,"document_id":{"jurisdiction":"US","doc_number":"5234957","kind":"A","date":"1993-08-10","name":"MANTELLE JUAN A [US]"},"lens_id":"157-779-708-992-259","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":41}},{"patent":{"num":42,"document_id":{"jurisdiction":"US","doc_number":"5288497","kind":"A","date":"1994-02-22","name":"STANLEY THEODORE H [US], et al"},"lens_id":"082-427-874-789-506","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":42}},{"patent":{"num":43,"document_id":{"jurisdiction":"US","doc_number":"5314904","kind":"A","date":"1994-05-24","name":"EGIDIO MARCHI [IT], et al"},"lens_id":"074-260-519-924-927","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":43}},{"patent":{"num":44,"document_id":{"jurisdiction":"US","doc_number":"5387420","kind":"A","date":"1995-02-07","name":"MITCHELL ROBIN P [BE]"},"lens_id":"105-033-385-555-961","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":44}},{"patent":{"num":45,"document_id":{"jurisdiction":"US","doc_number":"5401513","kind":"A","date":"1995-03-28","name":"WEHLING FRED [US], et al"},"lens_id":"145-308-214-860-751","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":45}},{"patent":{"num":46,"document_id":{"jurisdiction":"US","doc_number":"5445827","kind":"A","date":"1995-08-29","name":"FRITSCH CHRISTIAN [DE], et al"},"lens_id":"109-859-117-951-825","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":46}},{"patent":{"num":47,"document_id":{"jurisdiction":"US","doc_number":"5458879","kind":"A","date":"1995-10-17","name":"SINGH NIKHILESH N [US], et al"},"lens_id":"153-553-315-076-092","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":47}},{"patent":{"num":48,"document_id":{"jurisdiction":"US","doc_number":"5464632","kind":"A","date":"1995-11-07","name":"COUSIN GERARD [FR], et al"},"lens_id":"186-608-105-174-228","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":48}},{"patent":{"num":49,"document_id":{"jurisdiction":"US","doc_number":"5468504","kind":"A","date":"1995-11-21","name":"SCHAEFFER ALAIN EMILE EDOUARD [FR]"},"lens_id":"176-015-568-111-323","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":49}},{"patent":{"num":50,"document_id":{"jurisdiction":"US","doc_number":"5501861","kind":"A","date":"1996-03-26","name":"MAKINO TADASHI [JP], et al"},"lens_id":"040-585-083-228-286","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":50}},{"patent":{"num":51,"document_id":{"jurisdiction":"US","doc_number":"5503846","kind":"A","date":"1996-04-02","name":"WEHLING FRED [US], et al"},"lens_id":"064-905-590-807-929","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":51}},{"patent":{"num":52,"document_id":{"jurisdiction":"US","doc_number":"5550861","kind":"A","date":"1996-08-27","name":"CHAN DEMONDER [US], et al"},"lens_id":"014-531-204-883-29X","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":52}},{"patent":{"num":53,"document_id":{"jurisdiction":"US","doc_number":"5559096","kind":"A","date":"1996-09-24","name":"EDWARDS PETER J [GB], et al"},"lens_id":"008-710-050-555-993","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":53}},{"patent":{"num":54,"document_id":{"jurisdiction":"US","doc_number":"5607697","kind":"A","date":"1997-03-04","name":"ALKIRE TODD G [US], et al"},"lens_id":"129-403-086-439-991","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":54}},{"patent":{"num":55,"document_id":{"jurisdiction":"US","doc_number":"5624687","kind":"A","date":"1997-04-29","name":"YANO KATSUHIKO [JP], et al"},"lens_id":"155-329-328-459-347","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":55}},{"patent":{"num":56,"document_id":{"jurisdiction":"US","doc_number":"5626866","kind":"A","date":"1997-05-06","name":"EBERT CHARLES D [US], et al"},"lens_id":"196-756-525-068-568","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":56}},{"patent":{"num":57,"document_id":{"jurisdiction":"US","doc_number":"5635210","kind":"A","date":"1997-06-03","name":"ALLEN JR LOYD V [US], et al"},"lens_id":"166-611-119-895-837","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":57}},{"patent":{"num":58,"document_id":{"jurisdiction":"US","doc_number":"5646151","kind":"A","date":"1997-07-08","name":"KRUSE LAWRENCE I [US], et al"},"lens_id":"096-646-460-650-641","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":58}},{"patent":{"num":59,"document_id":{"jurisdiction":"US","doc_number":"5656284","kind":"A","date":"1997-08-12","name":"BALKIN MICHAEL S [US]"},"lens_id":"100-294-228-267-062","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":59}},{"patent":{"num":60,"document_id":{"jurisdiction":"US","doc_number":"5720974","kind":"A","date":"1998-02-24","name":"MAKINO TADASHI [JP], et al"},"lens_id":"047-391-923-104-155","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":60}},{"patent":{"num":61,"document_id":{"jurisdiction":"US","doc_number":"5785989","kind":"A","date":"1998-07-28","name":"STANLEY THEODORE H [US], et al"},"lens_id":"103-704-870-361-353","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":61}},{"patent":{"num":62,"document_id":{"jurisdiction":"US","doc_number":"5807688","kind":"A","date":"1998-09-15","name":"BLACKBURN GEORGE MICHAEL [GB], et al"},"lens_id":"049-145-131-573-104","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":62}},{"patent":{"num":63,"document_id":{"jurisdiction":"US","doc_number":"5851553","kind":"A","date":"1998-12-22","name":"MYERS GARRY L [US], et al"},"lens_id":"102-826-985-096-640","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":63}},{"patent":{"num":64,"document_id":{"jurisdiction":"US","doc_number":"5853748","kind":"A","date":"1998-12-29","name":"NEW ROGER RANDAL CHARLES [GB]"},"lens_id":"070-101-063-789-451","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":64}},{"patent":{"num":65,"document_id":{"jurisdiction":"US","doc_number":"5900252","kind":"A","date":"1999-05-04","name":"CALANCHI MASSIMO MARIA [IT], et al"},"lens_id":"148-263-546-220-219","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":65}},{"patent":{"num":66,"document_id":{"jurisdiction":"US","doc_number":"5948389","kind":"A","date":"1999-09-07","name":"STEIN CHRISTOPH [US]"},"lens_id":"085-977-048-059-961","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":66}},{"patent":{"num":67,"document_id":{"jurisdiction":"US","doc_number":"5952004","kind":"A","date":"1999-09-14","name":"RUDNIC EDWARD [US], et al"},"lens_id":"153-757-203-428-801","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":67}},{"patent":{"num":68,"document_id":{"jurisdiction":"US","doc_number":"5958455","kind":"A","date":"1999-09-28","name":"ROSER BRUCE J [GB], et al"},"lens_id":"143-657-362-460-322","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":68}},{"patent":{"num":69,"document_id":{"jurisdiction":"US","doc_number":"5958458","kind":"A","date":"1999-09-28","name":"NORLING TOMAS [DK], et al"},"lens_id":"034-846-597-702-753","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":69}},{"patent":{"num":70,"document_id":{"jurisdiction":"US","doc_number":"6034085","kind":"A","date":"2000-03-07","name":"JOSHI HEMANT N [US], et al"},"lens_id":"034-352-671-121-720","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":70}},{"patent":{"num":71,"document_id":{"jurisdiction":"US","doc_number":"6068853","kind":"A","date":"2000-05-30","name":"GIANNOS STEVEN ANDREW [US], et al"},"lens_id":"060-963-018-615-387","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":71}},{"patent":{"num":72,"document_id":{"jurisdiction":"US","doc_number":"6106861","kind":"A","date":"2000-08-22","name":"CHAUVEAU CHARLES [FR], et al"},"lens_id":"159-498-563-297-416","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":72}},{"patent":{"num":73,"document_id":{"jurisdiction":"US","doc_number":"6117912","kind":"A","date":"2000-09-12","name":"DISANTO ANTHONY R [US]"},"lens_id":"075-664-652-574-900","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":73}},{"patent":{"num":74,"document_id":{"jurisdiction":"US","doc_number":"6129906","kind":"A","date":"2000-10-10","name":"STEVENTON ANTHONY JAMES [GB]"},"lens_id":"091-810-283-975-401","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":74}},{"patent":{"num":75,"document_id":{"jurisdiction":"US","doc_number":"6155423","kind":"A","date":"2000-12-05","name":"KATZNER LEO D [US], et al"},"lens_id":"042-760-876-240-902","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":75}},{"patent":{"num":76,"document_id":{"jurisdiction":"US","doc_number":"6171617","kind":"B1","date":"2001-01-09","name":"GRUBER PETER [CH]"},"lens_id":"062-533-297-122-122","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":76}},{"patent":{"num":77,"document_id":{"jurisdiction":"US","doc_number":"6190697","kind":"B1","date":"2001-02-20","name":"GERGELY GERHARD [AT], et al"},"lens_id":"078-263-822-149-045","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":77}},{"patent":{"num":78,"document_id":{"jurisdiction":"US","doc_number":"6200604","kind":"B1","date":"2001-03-13","name":"PATHER SATHASIVAN INDIRAN [US], et al"},"lens_id":"082-872-907-517-255","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":78}},{"patent":{"num":79,"document_id":{"jurisdiction":"US","doc_number":"6242002","kind":"B1","date":"2001-06-05","name":"TRITTHART WOLFRAM [AU], et al"},"lens_id":"042-504-250-296-901","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":79}},{"patent":{"num":80,"document_id":{"jurisdiction":"US","doc_number":"6262062","kind":"B1","date":"2001-07-17","name":"CLEMENS ANTON H [US]"},"lens_id":"037-865-472-151-196","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":80}},{"patent":{"num":81,"document_id":{"jurisdiction":"US","doc_number":"6264981","kind":"B1","date":"2001-07-24","name":"ZHANG HAO [US], et al"},"lens_id":"140-511-345-046-807","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":81}},{"patent":{"num":82,"document_id":{"jurisdiction":"US","doc_number":"6284274","kind":"B1","date":"2001-09-04","name":"MERRILL SONYA [US], et al"},"lens_id":"134-157-091-462-061","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":82}},{"patent":{"num":83,"document_id":{"jurisdiction":"US","doc_number":"6316027","kind":"B1","date":"2001-11-13","name":"JOHNSON EDWARD STEWART [GB], et al"},"lens_id":"075-379-998-359-906","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":83}},{"patent":{"num":84,"document_id":{"jurisdiction":"US","doc_number":"6326360","kind":"B1","date":"2001-12-04","name":"KANAZAWA HASHIME [JP], et al"},"lens_id":"141-254-294-373-649","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":84}},{"patent":{"num":85,"document_id":{"jurisdiction":"US","doc_number":"6326384","kind":"B1","date":"2001-12-04","name":"WHITTLE ROBERT R [US], et al"},"lens_id":"102-318-437-020-425","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":85}},{"patent":{"num":86,"document_id":{"jurisdiction":"US","doc_number":"6350470","kind":"B1","date":"2002-02-26","name":"PATHER S INDIRAN [US], et al"},"lens_id":"184-675-423-418-723","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":86}},{"patent":{"num":87,"document_id":{"jurisdiction":"US","doc_number":"6368625","kind":"B1","date":"2002-04-09","name":"SIEBERT JOHN M [US], et al"},"lens_id":"158-860-856-615-708","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":87}},{"patent":{"num":88,"document_id":{"jurisdiction":"US","doc_number":"6391335","kind":"B1","date":"2002-05-21","name":"PATHER S INDIRAN [US], et al"},"lens_id":"044-945-129-100-133","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":88}},{"patent":{"num":89,"document_id":{"jurisdiction":"US","doc_number":"6488961","kind":"B1","date":"2002-12-03","name":"ROBINSON JOSEPH R [US], et al"},"lens_id":"159-495-305-801-137","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":89}},{"patent":{"num":90,"document_id":{"jurisdiction":"US","doc_number":"6509036","kind":"B2","date":"2003-01-21","name":"PATHER S INDIRAN [US], et al"},"lens_id":"170-043-442-735-691","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":90}},{"patent":{"num":91,"document_id":{"jurisdiction":"US","doc_number":"6576250","kind":"B1","date":"2003-06-10","name":"PATHER S INDIRAN [US], et al"},"lens_id":"156-675-482-451-827","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":91}},{"patent":{"num":92,"document_id":{"jurisdiction":"US","doc_number":"6641838","kind":"B2","date":"2003-11-04","name":"PATHER S INDIRAN [US], et al"},"lens_id":"177-170-537-125-980","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":92}},{"patent":{"num":93,"document_id":{"jurisdiction":"US","doc_number":"6680071","kind":"B1","date":"2004-01-20","name":"JOHNSON EDWARD STEWART [GB], et al"},"lens_id":"030-738-595-585-73X","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":93}},{"patent":{"num":94,"document_id":{"jurisdiction":"US","doc_number":"6759059","kind":"B1","date":"2004-07-06","name":"PETTERSSON ANDERS [SE], et al"},"lens_id":"177-704-334-966-10X","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":94}},{"patent":{"num":95,"document_id":{"jurisdiction":"US","doc_number":"6761910","kind":"B1","date":"2004-07-13","name":"PETTERSSON ANDERS [SE], et al"},"lens_id":"093-345-771-752-575","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":95}},{"patent":{"num":96,"document_id":{"jurisdiction":"US","doc_number":"6764696","kind":"B2","date":"2004-07-20","name":"PATHER S INDIRAN [US], et al"},"lens_id":"179-463-747-417-254","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":96}},{"patent":{"num":97,"document_id":{"jurisdiction":"US","doc_number":"6835194","kind":"B2","date":"2004-12-28","name":"JOHNSON RANDOLPH MELLUS [US], et al"},"lens_id":"029-441-367-030-764","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":97}},{"patent":{"num":98,"document_id":{"jurisdiction":"US","doc_number":"7670617","kind":"B2","date":"2010-03-02","name":"PATHER S INDIRAN [US], et al"},"lens_id":"068-853-440-535-247","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":98}},{"patent":{"num":99,"document_id":{"jurisdiction":"US","doc_number":"2001006677","kind":"A1","date":"2001-07-05","name":"MCGINITY JAMES W [US], et al"},"lens_id":"143-954-072-287-411","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":99}},{"npl":{"num":1,"text":"Order-In the United States District Court for the district of Delaware, Cephalon, Inc., and CIMA Labs, Inc., Civil No. 08-330-SLR, Mar. 11, 2011.","npl_type":"a","external_id":[],"lens_id":[],"sequence":100,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":2,"text":"Plaintiffs' Amended Notice of Appeal to the United States Court of Appeals for the Federal Circuit, Case: 1:08-cv-00330-SLR, Document 339 Filed Apr. 26, 2011.","npl_type":"a","external_id":[],"lens_id":[],"sequence":101,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":3,"text":"Notice of Docketing, United States Court of Appeals for the Federal Circuit, Case: 1:08-cv-00330-SLR, Document 340, Filed May 9, 2011.","npl_type":"a","external_id":[],"lens_id":[],"sequence":102,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":4,"text":"Brief for Plaintiffs-Appellants, United States Court of Appeals for the Federal Circuit, Cephalon, Inc. and CIMA Labs, Inc., Appeal No. 2011-1325, dated Nov. 16, 2011.","npl_type":"a","external_id":[],"lens_id":[],"sequence":103,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":5,"text":"Brief for defendants Appellees, United States Court of Appeals for the Federal Circuit, Cephalon, Inc. and CIMA Labs, Inc., Appeal No. 2011-1325, dated May 18, 2012.","npl_type":"a","external_id":[],"lens_id":[],"sequence":104,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":6,"text":"Alternative Routes of Drug Administration-Advantages and Disadvantages (Subject Review), American Academy of Pediatrics Committee on Drugs, Pediatrics, vol. 100(1), pp. 143, 147, Jul. 1997.","npl_type":"a","external_id":["9229706","10.1542/peds.100.1.143"],"record_lens_id":"060-206-697-327-273","lens_id":["097-572-977-821-316","060-206-697-327-273","115-446-704-379-474"],"sequence":105,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":7,"text":"Altomare, E. et al., \"Bioavailability of a New Effervescent Tablet of Ibuprofen in Healthy Volunteers\", Eur. J. Clin. Pharmacol. vol. 52, pp. 505-506, (1997).","npl_type":"a","external_id":["10.1007/s002280050327","9342589"],"record_lens_id":"042-660-327-211-051","lens_id":["193-821-802-918-364","042-660-327-211-051","045-141-833-604-389"],"sequence":106,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":8,"text":"Amighi, K. et al., \"Peroral Sustained-Release Film-Coated Pellets as a Means to Overcome Physiochemical and Biological Drug-Related Problems\", In Vitro Development and Evaluation, Drug Development and Industrial pharmacy, vol. 24(6), pp. 509-551 (1998).","npl_type":"a","external_id":["9876616","10.3109/03639049809085651"],"record_lens_id":"033-301-228-623-746","lens_id":["142-714-596-941-067","033-301-228-623-746","052-451-812-623-561"],"sequence":107,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":9,"text":"Audus, K.L., \"Buccal Epithelial Cell Cultures as a Model to Study Oral Mucosal Drug Transport and Metabolism\", Oral Mucosal Drug Delivery, Chptr 6, pp. 101-115 (1996).","npl_type":"a","external_id":[],"lens_id":[],"sequence":108,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":10,"text":"Audus, K.L. et al., \"The Use of Cultured Epithelial and Endothelial Cells for Drug Transport and Metabolism Studies\", Pharmaceutical Research, vol. 7(5), p. 435, (1990).","npl_type":"a","external_id":["2195492","10.1023/a:1015800312910"],"record_lens_id":"023-763-190-193-149","lens_id":["179-335-625-320-845","023-763-190-193-149","035-491-889-423-349"],"sequence":109,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":11,"text":"Aungst, B.J., \"Oral Mucosal Permeation Enhancement: Possibilities and Limitations\", Oral Mucosal Drug Deliver, Chptr 4, pp. 65-81 (1996).","npl_type":"a","external_id":[],"lens_id":[],"sequence":110,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":12,"text":"Berko, S. et al., \"Influence of pH Change on Drug Release from Rectal Suppositories\", Die Pharmazie, vol. 55, p. 324, (Apr. 2000), Govi-Verlag Pharmazeutischer Verlag ChmH, Eshborn.","npl_type":"a","external_id":["10798253"],"record_lens_id":"067-332-055-723-663","lens_id":["154-414-754-884-848","067-332-055-723-663"],"sequence":111,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":13,"text":"Bredenberg, Susanne, \"New Concepts in Administration of Drugs in Tablet Form\", Thesis (Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 287) pp. 1-77, (2003).","npl_type":"a","external_id":[],"lens_id":[],"sequence":112,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":14,"text":"Chen et al., \"Studies on Formulations of Fentanyl Buccal Adhesive Tablets\", Zhongguo Yiyao Gongye Zazhi, vol. 28(3), pp. 129-131 (1997).","npl_type":"a","external_id":[],"lens_id":[],"sequence":113,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":15,"text":"Clinical Pharmacology FDA Submission, Clinical Pharmacology and Biopharmaceutics Reviews, NDA 21-947, Fentanyl Effervescent Buccal Tablet DFS, pp. 1-86, 31 pages withheld, 2006.","npl_type":"a","external_id":[],"lens_id":[],"sequence":114,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":16,"text":"Coluzzi et al., \"Breakthrough Cancer Pain\" A Randomized Trial Comparing Oral Transmucosal Fentanyl Citrate (OTFC®) and Morphine Sulfate Immediate Release (MSIR®), Pain vol. 91, pp. 123-130, (2001).","npl_type":"a","external_id":["11240084","10.1016/s0304-3959(00)00427-9"],"record_lens_id":"049-557-686-429-561","lens_id":["153-903-386-651-493","049-557-686-429-561","192-142-646-236-175"],"sequence":115,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":17,"text":"Conine, James W., \"Special Tablets in Pharmaceutical Dosage Forms\", Tablets, vol. 1, p. 329 (Herbert A. Lieberman et al. eds.) 1989.","npl_type":"a","external_id":[],"lens_id":[],"sequence":116,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":18,"text":"Coster ltr to the Speaker, Leader and Director re: Protecting Funding for FDA Office of Generic Drugs in Final 2011 Budget, dated Mar. 18 2011.","npl_type":"a","external_id":[],"lens_id":[],"sequence":117,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":19,"text":"Darwish, M. et al., \"Absolute and Relative Bioavailability of Fentanyl Buccal Tablet and Oral Transmucosal Fentanyl Citrate\", J. Clin. Pharmacol. vol. 47, pp. 343-350 (2007).","npl_type":"a","external_id":["10.1177/0091270006297749","17322146"],"record_lens_id":"149-432-991-298-584","lens_id":["152-462-950-404-892","149-432-991-298-584","163-360-243-761-606"],"sequence":118,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":20,"text":"Darwish, M. et al., \"Relative Bioavailability and Dose Proportionality of a Novel Effervescent Form of Fentanyl in Healthy Volunteers\", Anesthesiology, vol. 103 A790, (Oct. 24, 2005).","npl_type":"a","external_id":[],"lens_id":[],"sequence":119,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":21,"text":"Darwish, M. et al., \"Pharmacokinetics and Dose Proportionality of Fentanyl Effervescent Buccal Tablets in Healthy Volunteers\", Clin. Pharmacol. vol. 44(12), pp. 1279-1286, (2005).","npl_type":"a","external_id":["10.2165/00003088-200544120-00006","16372825"],"record_lens_id":"143-409-581-656-840","lens_id":["174-658-108-539-966","143-409-581-656-840","147-536-134-542-54X"],"sequence":120,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":22,"text":"DeGrande et al., \"Specialized Oral Mucosal Drug Delivery Systems: Patches\", Oral Mucosal Drug Delivery, Chptr 12, pp. 285-313 (1998).","npl_type":"a","external_id":[],"lens_id":[],"sequence":121,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":23,"text":"Eichman, Jonathan D., \"Increased Drug Absorption Through Carbonation: Assessment of Biological Membranes\", A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science (Pharmaceutics) at the University of WI-Madison, (1995).","npl_type":"a","external_id":[],"lens_id":[],"sequence":122,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":24,"text":"Eichman, Jonathan D., \"Mechanistic Studies in Effervescent-Induced Permeability Enhancement\", Dissertation, U of WI-Madison, 1997, pp. 1-24, catalogued Sep. 18, 1998.","npl_type":"a","external_id":[],"lens_id":[],"sequence":123,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":25,"text":"Eichman et al., \"Mechanistic Studies on Effervescent-Induced Permeability Enhancement\", Pharm. Res. vol. 15(6), pp. 925-930 (1998).","npl_type":"a","external_id":["10.1023/a:1011936901638","9647360"],"record_lens_id":"018-918-095-866-678","lens_id":["071-794-610-711-911","018-918-095-866-678","176-090-431-669-801"],"sequence":124,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":26,"text":"Eichman, Jonathan D., \"The Influence of In-Vivo Carbonation on GI Physiological Processes and Drug Permeability\", Eur. J. Pharmaceutics and Biopharmaceutics, vol. 44, pp. 33-38, (1997), catalogued Sep. 18, 1998.","npl_type":"a","external_id":["10.1016/s0939-6411(97)00099-4"],"record_lens_id":"019-685-369-636-928","lens_id":["158-331-558-876-471","019-685-369-636-928"],"sequence":125,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":27,"text":"EP Communication from EP Patent Office, EP Patent Application No. 04815715.0, dated Mar. 28, 2008.","npl_type":"a","external_id":[],"lens_id":[],"sequence":126,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":28,"text":"EP Search Report for EP Patent Application No. EP 00919523 dated Apr. 29, 2002.","npl_type":"a","external_id":[],"lens_id":[],"sequence":127,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":29,"text":"EP Supplemental Search Report for EP Patent Application No. 04815715 dated Nov. 14, 2007.","npl_type":"a","external_id":[],"lens_id":[],"sequence":128,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":30,"text":"EP Search Report for EP Patent Application No. EP 00926341 dated Nov. 23, 2005.","npl_type":"a","external_id":[],"lens_id":[],"sequence":129,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":31,"text":"Exhibits A-J, Redacted in its Entirety, Exhibit I, Memorandum Order dated Sep. 21, 2010, Exhibit J., Oct. 23, 2009, Memorandum, Order in re: Brimonidine Patent Litigation, Exhibit K, Feb. 9, 2011, Fish & Richardson ltr re: Ceph et al. v. Sandoz, Order Compelling Sandoz to Produce Documents.","npl_type":"a","external_id":[],"lens_id":[],"sequence":130,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":32,"text":"Fentora® (Fentanyl Buccal Tablet) Label, 9 pages, Oct. 2007.","npl_type":"a","external_id":[],"lens_id":[],"sequence":131,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":33,"text":"Fish & Richardson Ltr to Stronski, Ceph et al. v. Watson re: Alleged Deficiencies in Cephalon's Response to Watson's Interrogatory No. 2, dated May 29, 2009.","npl_type":"a","external_id":[],"lens_id":[],"sequence":132,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":34,"text":"Giannos et al., \"Temporally Controlled Drug Systems: Coupling of pH Oscillators with Membrane Diffusion\", Journal of Pharmaceutical Sciences, vol. 84(5), pp. 539-543, May 1995.","npl_type":"a","external_id":["10.1002/jps.2600840505","7658341"],"record_lens_id":"038-879-021-531-740","lens_id":["152-091-988-293-921","038-879-021-531-740","060-312-668-418-335"],"sequence":133,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":35,"text":"Hagerstrom, Helene, \"Polymer Gels as Pharmaceutical Dosage Forms\", Thesis (Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 293) 2003.","npl_type":"a","external_id":[],"lens_id":[],"sequence":134,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":36,"text":"Hagerstrom, Helene, \"Polymer Gels as Pharmaceutical Dosage Forms: Rheological Performance and Physicochemical Interactions at the Gel-Mucus Interface for Formulations Intended for Mucosal Drug Delivery\", Theses from Uppsala University: 3538-Polymer Gels as Pharmaceutical Dosage Forms, pp. 1-3, htto://ou blications. uu. se/theses/abstract.xsql?dbid=3538&lang=en, 2004.","npl_type":"a","external_id":[],"lens_id":[],"sequence":135,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":37,"text":"Harris, D. et al., \"Drug Delivery via the Mucous Membranes of the Oral Cavity\", Journal of Pharmaceutical Sciences, vol. 81(1), pp. 1-10 (1992).","npl_type":"a","external_id":["1619560","10.1002/jps.2600810102"],"record_lens_id":"009-467-410-639-998","lens_id":["077-659-676-097-391","009-467-410-639-998","169-779-666-070-98X"],"sequence":136,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":38,"text":"Hessell, P.G., et al., \"A Comparison of the Availability of Prochlorperazine Following I.M. Buccal and Oral Administration\", International Journal of Pharmaceutics, vol. 52(2), pp. 159-164, Jun. 1, 1989.","npl_type":"a","external_id":["10.1016/0378-5173(89)90291-3"],"record_lens_id":"121-524-123-597-711","lens_id":["160-506-418-525-091","121-524-123-597-711"],"sequence":137,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":39,"text":"http://Chemical1and21.com/industrialchem/inorganic/Sodium%20Sulphate.htm, Sodium Sulfate, 2 pages, 2012.","npl_type":"a","external_id":[],"lens_id":[],"sequence":138,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":40,"text":"Impax Lab, Paragraph IV Certification Notice, dated Oct. 6, 2011.","npl_type":"a","external_id":[],"lens_id":[],"sequence":139,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":41,"text":"International Search Report for PCT Application No. PCT/US00/07567, dated Jul. 5, 2000.","npl_type":"a","external_id":[],"lens_id":[],"sequence":140,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":42,"text":"International Search Report for PCT Application No. PCT/US04/43703, dated Nov. 1, 2005.","npl_type":"a","external_id":[],"lens_id":[],"sequence":141,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":43,"text":"Kellaway et al., \"Mucoadhesive Hydrogels for Buccal Delivery\", Oral Mucosal Drug Delivery, Chptr. 10, pp. 221-237, (1996).","npl_type":"a","external_id":[],"lens_id":[],"sequence":142,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":44,"text":"Kramer et al., \"Pharmacodynamic Model of the Effects of Morphine and Morphine-6-Glucoronide During Patient-Controlled Analgesia\", American Society for Clinical Pharmacology and Therapeutics, Clinical Pharmacology & Therapeutics, vol. 59(2), p. 132, Feb. 1996.","npl_type":"a","external_id":["10.1038/sj.clpt.1996.28"],"record_lens_id":"111-340-305-147-018","lens_id":["152-709-999-569-120","111-340-305-147-018"],"sequence":143,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":45,"text":"Labroo, RB et al., \"Fentanyl Metabolism by Human Hepatic and Intestinal Cytochrome P450 3A4: Implications for Interindividual Variability in Disposition, Efficacy, and Drug Interactions\", Drug Metabolism and Disposition, vol. 25(9): pp. 1072-1080, (1997).","npl_type":"a","external_id":["9311623"],"record_lens_id":"012-007-129-578-370","lens_id":["024-209-349-097-318","012-007-129-578-370"],"sequence":144,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":46,"text":"Malpani, \"Sodium Starch Glycolate\", 13 pages, Jan. 5, 2010.","npl_type":"a","external_id":[],"lens_id":[],"sequence":145,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":47,"text":"Mendes et al., \"Chewable Tablets\", Pharmaceutical Dosage Forms Tablets, Edited by H.A. Lieberman, 2nd Edition, vol. 1, pp. 372-376, 1989.","npl_type":"a","external_id":[],"lens_id":[],"sequence":146,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":48,"text":"Mylan et al. Notice of Paragraph IV Certification: Amendment to ANDA No. 202577 Fentanyl Citrate Buccal Tablets, (Flynn), dated Sep. 28, 2011.","npl_type":"a","external_id":[],"lens_id":[],"sequence":147,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":49,"text":"Nishimura et al., \"Dosage Form Design for Improvement of Bioavailability of Levodopa VI: Formulation of Effervescent Enteric-Coated Tablets\", Journal of Pharmaceutical Sciences, vol. 73(7), Jul. 1984.","npl_type":"a","external_id":["10.1002/jps.2600730720","6088756"],"record_lens_id":"038-122-042-388-627","lens_id":["128-543-711-933-206","038-122-042-388-627","188-970-630-849-38X"],"sequence":148,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":50,"text":"Notice of Reference re: U.S. Appl. No. 12/955,346, 2011.","npl_type":"a","external_id":[],"lens_id":[],"sequence":149,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":51,"text":"Palmisano, Clinical Review of Fentanyl Oralet (Oral Transmucosal Fentanyl Citrate), NDA Application No. 20-195/S-002, dated Feb. 26, 1996.","npl_type":"a","external_id":[],"lens_id":[],"sequence":150,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":52,"text":"U.S. Appl. No. 09/661,693, filed Sep. 14, 2000.","npl_type":"a","external_id":[],"lens_id":[],"sequence":151,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":53,"text":"Pather et al., \"Enhanced Buccal Delivery of Fentanyl Using the OraVescent Drug Delivery System\", Buccal Delivery, vol. 1(1), 6 pages, Oct. 2001.","npl_type":"a","external_id":[],"lens_id":[],"sequence":152,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":54,"text":"Physician's Desk Reference Actiq, pp. 1151-1155, 2004.","npl_type":"a","external_id":[],"lens_id":[],"sequence":153,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":55,"text":"Physician's Desk Reference Kadian, pp. 569-573, 2005.","npl_type":"a","external_id":[],"lens_id":[],"sequence":154,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":56,"text":"Portenoy et al., \"Breakthrough Pain: Definition, Prevalence and Characteristics\", Pain, vol. (41), pp. 273-281 (1990).","npl_type":"a","external_id":["1697056","10.1016/0304-3959(90)90004-w"],"record_lens_id":"106-350-499-249-183","lens_id":["148-237-324-819-518","106-350-499-249-183","117-126-829-082-084"],"sequence":155,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":57,"text":"Portenoy et al., \"Fentanyl Buccal Tablet (FBT) for Relief of Breakthrough Pain in Opioid-Treated Patients with Chronic Low Back Pain: A Randomized, Placebo-Controlled Study\", Fentanyl Buccal Tablet for Breakthrough Pain, vol. 23(1), pp. 223-233, (2007).","npl_type":"a","external_id":["10.1185/030079906x162818","17207304"],"record_lens_id":"003-186-383-557-487","lens_id":["173-712-249-766-28X","003-186-383-557-487","189-458-158-328-882"],"sequence":156,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":58,"text":"Ranade, \"Drug Delivery Systems 5B. Oral Drug Delivery\", Drug Delivery Systems Series, J. Clin. Pharmaco., vol. 31, pp. 98-115, (1991).","npl_type":"a","external_id":["10.1002/j.1552-4604.1991.tb03693.x","2010566"],"record_lens_id":"041-022-406-703-799","lens_id":["153-019-341-464-451","041-022-406-703-799","059-796-044-854-962"],"sequence":157,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":59,"text":"Rassing, R. \"Specialized Oral Mucosal Drug Delivery Systems: Chewing Gum\", Oral Mucosal Drug Delivery, Chptr. 13, pp. 319-353, (1996).","npl_type":"a","external_id":[],"lens_id":[],"sequence":158,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":60,"text":"Rathbone et al., \"In Vivo Techniques for Studying the Oral Mucosal Absorption Characteristics of Drugs in Animals and Humans\", Oral Mucosal Drug Delivery, Chptr. 7, pp. 121-151, (1996).","npl_type":"a","external_id":[],"lens_id":[],"sequence":159,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":61,"text":"Rathbone et al., \"Systemic Oral Mucosal Drug Delivery and Delivery Systems\", Oral Mucosal Drug Delivery, Chptr 11, pp. 241-275 (1996).","npl_type":"a","external_id":[],"lens_id":[],"sequence":160,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":62,"text":"Reisine et al., \"Opioid Analgesics and Antagonists\", in Hardman, J.G. et al., editors. Goodman and Gilman's Pharmacologic Basis of Therapeutics, 9th Rev. Ed. New York: McGraw Hill, pp. 521-555, (1996).","npl_type":"a","external_id":[],"lens_id":[],"sequence":161,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":63,"text":"Rowe et al., \"Handbook of Pharmaceutical Excipients\", Fifth Edition, pp. 758-759, (2006).","npl_type":"a","external_id":[],"lens_id":[],"sequence":162,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":64,"text":"Sasahara et al., \"Dosage Form Design for Improvement of Bioavailability of Levodopa II: Bioavailability of Marketed Levodopa Preparations in Dogs and Parkinsonian Patients\", J. Pharm. Sci. vol. 69(3), pp. 261-265, (1980).","npl_type":"a","external_id":["10.1002/jps.2600690304","7381698"],"record_lens_id":"077-378-890-158-086","lens_id":["123-736-832-311-007","077-378-890-158-086","124-109-528-638-949"],"sequence":163,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":65,"text":"Sasahara et al., \"Dosage Form Design for Improvement of Bioavailability of Levodopa III: Influence of Dose on Pharmacokinetic Behavior of Levodopa in Dogs and Parkinsonian Patients\", J. Pharm. Sci. vol. 69(12), pp. 1374-1378, (1980).","npl_type":"a","external_id":["10.1002/jps.2600691205","7463319"],"record_lens_id":"025-674-072-953-862","lens_id":["124-520-123-231-77X","025-674-072-953-862","106-555-722-124-084"],"sequence":164,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":66,"text":"Sasahara et al., \"Dosage Form Design for Improvement of Bioavailability of Levodopa IV: Possible Causes of Low Bioavailability of Oral Levodopa in Dogs\", J. Pharm. Sci., vol. 70(7), pp. 730-733, (1981).","npl_type":"a","external_id":["10.1002/jps.2600700705","7264915"],"record_lens_id":"063-524-820-161-727","lens_id":["099-709-793-592-499","063-524-820-161-727","084-352-029-293-051"],"sequence":165,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":67,"text":"Sasahara et al., \"Dosage Form Design for Improvement of Bioavailability of Levodopa V: Absorption and Metabolism of Levodopa in Intestinal Segments of Dogs\", J. Pharm. Sci., vol. 70(10), pp. 1157-1160, (1981).","npl_type":"a","external_id":["7299652","10.1002/jps.2600701018"],"record_lens_id":"031-025-669-329-007","lens_id":["117-330-468-145-77X","031-025-669-329-007","066-471-283-213-095"],"sequence":166,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":68,"text":"Schenkels et al., \"Salivary Mucins: Their Role in Oral Mucosal Barrier Function and Drug Delivery\", Oral Mucosal Drug Delivery, Chptr 9, pp. 191-211, (1996).","npl_type":"a","external_id":[],"lens_id":[],"sequence":167,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":69,"text":"Scott et al., \"EEG Quantification of Narcotic Effect: The Comparative Pharmacodynamics of Fentanyl and Alfentanil\", Anesthesiology, vol. 62: pp. 234-241 (1985).","npl_type":"a","external_id":["10.1097/00000542-198503000-00005","3919613"],"record_lens_id":"003-465-903-841-361","lens_id":["152-320-814-344-959","003-465-903-841-361","159-673-060-707-845"],"sequence":168,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":70,"text":"Sorasuchart et al., \"Drug Release from Spray Layered and Coated Drug-Containing Beads: Effects of pH and Comparison of Different Dissolution Methods\", Drug Development and Industrial Pharmacy, vol. 25(10), pp. 1093-1098, (1999).","npl_type":"a","external_id":["10529889","10.1081/ddc-100102274"],"record_lens_id":"008-755-997-859-235","lens_id":["077-412-220-409-735","008-755-997-859-235","050-467-091-376-954"],"sequence":169,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":71,"text":"Soskolone et al., \"Intra-periodontal Pocket Drug Delivery Systems\", Oral Mucosal Drug Delivery, Chptr. 14, pp. 359-373, (1996).","npl_type":"a","external_id":[],"lens_id":[],"sequence":170,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":72,"text":"Squier et al., \"Structure and Function of the Oral Mucosa and Implications for Drug Delivery\", Oral Mucosal Drug Delivery, Chptr. 1, pp. 1-19, (1996).","npl_type":"a","external_id":[],"lens_id":[],"sequence":171,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":73,"text":"Stanley et al., \"Novel Delivery Systems: Oral Transmucosal and Intranasal Transmucosal\", Journal of Pain and Symptom Management, vol. 7(3): 163-171 (1992).","npl_type":"a","external_id":["10.1016/s0885-3924(06)80009-6","16967585"],"record_lens_id":"060-914-091-123-118","lens_id":["148-165-062-361-42X","060-914-091-123-118","118-372-647-291-950"],"sequence":172,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":74,"text":"Sterne Kessler et al., Ltr re: Barr Supplemental Notification Pursuant to §505(j)(2)(B)(ii) of the Federal Food, Drug, and Cosmetic Act, 7 pages, Dated Dec. 22, 2008.","npl_type":"a","external_id":[],"lens_id":[],"sequence":173,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":75,"text":"Sterne Kessler et al., Ltr. re: Supplemental Notification Pursuant to §505(j)(2)(B)(ii) of the Federal Food, Drug, and Cosmetic Act, 7 pages, Dated Jun. 27, 2008.","npl_type":"a","external_id":[],"lens_id":[],"sequence":174,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":76,"text":"Sterne Kessler et al., Ltr. re: Notification Pursuant to §505(j)(2)(B)(ii) of the Federal Food, Drug, and Cosmetic Act, 9 pages, Dated Jun. 9, 2008.","npl_type":"a","external_id":[],"lens_id":[],"sequence":175,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":77,"text":"Streisand et al., \"Absorption and Bioavailability of Oral Transmucosal Fentanyl Citrate\", Anesthesiology, vol. 75(2), pp. 223-229, (1991).","npl_type":"a","external_id":["10.1097/00000542-199108000-00009","1859010"],"record_lens_id":"012-084-508-701-85X","lens_id":["196-197-739-081-161","012-084-508-701-85X","051-825-884-930-787"],"sequence":176,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":78,"text":"Streisand et al., \"Buccal Absorption of Fentanyl is pH-Dependent in Dogs\", Anesthesiology, vol. 82(3), pp. 759-764, Mar. 1995.","npl_type":"a","external_id":["7879944","10.1097/00000542-199503000-00018"],"record_lens_id":"091-378-120-524-649","lens_id":["119-961-879-142-235","091-378-120-524-649","151-221-211-316-342"],"sequence":177,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":79,"text":"Streubel et al., \"pH-Independent Release of a Weakly Basic Drug from Water-Insoluble and -Soluble Matrix Tablets\", Journal of Controlled Release, vol. 67, pp. 101-110, (2000).","npl_type":"a","external_id":["10773333","10.1016/s0168-3659(00)00200-5"],"record_lens_id":"115-061-186-240-175","lens_id":["194-932-565-193-723","115-061-186-240-175","151-500-323-221-69X"],"sequence":178,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":80,"text":"The Alcohol and Other Drug Thesaurus, National Institute of Health, National Institute on Alcohol Abuse and Alcoholics, U.S. Department of Human Services, Third Edition 2000, AOD Thesaurus Annotated Hierarchy: Biomedicine EF EG 16.2, pp. 1-12, Sep. 13, 2004.","npl_type":"a","external_id":[],"lens_id":[],"sequence":179,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":81,"text":"Wada, et al., Decision on Appeal 2007-3733, re: U.S. Appl. No. 10/613,220, pp. 1-9, Decided Jan. 14, 2008.","npl_type":"a","external_id":[],"lens_id":[],"sequence":180,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":82,"text":"Watson, Notification of Certification of Paragraph IV to Ceph. et al., dated Apr. 15, 2008.","npl_type":"a","external_id":[],"lens_id":[],"sequence":181,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":83,"text":"Weatherell et al., \"The Flow of Saliva and its Influence on the Movement, Deposition, and Removal of Drugs Administered to the Oral Cavity\", Oral Mucosal Drug Delivery, Chptr. 8, pp. 157-187, (1996).","npl_type":"a","external_id":[],"lens_id":[],"sequence":182,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":84,"text":"Weinberg et al., \"Sublingual Absorption of Selected Opioid Analgesics\", Clinical Pharmacology and Therapeutics, vol. 44(3), pp. 335-342, Sep. 1988.","npl_type":"a","external_id":["2458208","10.1038/clpt.1988.159"],"record_lens_id":"081-319-858-251-111","lens_id":["127-701-769-307-894","081-319-858-251-111","177-503-287-132-709"],"sequence":183,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":85,"text":"Wertz et al., \"Biochemical Basis of the Permeability Barrier in Skin and Oral Mucosa\", Oral Mucosal Drug Delivery, Chptr. 2, pp. 27-41, (1996).","npl_type":"a","external_id":[],"lens_id":[],"sequence":184,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":86,"text":"Zhang et al., \"In Vitro Methods for Measuring Permeability of the Oral Mucosa\", Oral Mucosal Drug Delivery, Chptr 5, pp. 85-97, (1996).","npl_type":"a","external_id":[],"lens_id":[],"sequence":185,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":87,"text":"Zhang et al., \"Routes of Drug Transport Across Oral Mucosa\", Oral Mucosal Drug Delivery, Chptr. 3, pp. 51-61, (1996).","npl_type":"a","external_id":[],"lens_id":[],"sequence":186,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":88,"text":"May 2, 2011 Redacted Version of 105 Plaintiff's Reply Brief in Support of Plaintiff's Motion to Stay Proceedings (Attachments #1 Ex. A).","npl_type":"a","external_id":[],"lens_id":[],"sequence":187,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":89,"text":"May 2, 2011 Redacted Version of 108 Declaration of Oakes in Support of Plaintiffs Opening Claim Construction Brief by Plaintiffs.","npl_type":"a","external_id":[],"lens_id":[],"sequence":188,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":90,"text":"May 2, 2011 Redacted Version of 107 Claim Construction Opening Brief Plaintiff's Opening Claim Construction Brief.","npl_type":"a","external_id":[],"lens_id":[],"sequence":189,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":91,"text":"Apr. 27, 2011 Request for Oral Arguments by Sandoz re 88 Motion to Stay Plaintiffs Motion to Stay Proceedings.","npl_type":"a","external_id":[],"lens_id":[],"sequence":190,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":92,"text":"Apr. 26, 2011 Request for Oral Arguments by Cephalon et al. re 88 Motion to Stay Plaintiffs Motion to Stay Proceedings.","npl_type":"a","external_id":[],"lens_id":[],"sequence":191,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":93,"text":"Apr. 21, 2011 Redacted Version of 98 Answering Brief in Opposition, Part 1 of 3 by Sandoz Inc., (Attachments: # 1 Part 2 of 3, # 2 Part 3 of 3).","npl_type":"a","external_id":[],"lens_id":[],"sequence":192,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":94,"text":"2011 Ceph et al., v. Sandoz Proposed Order.","npl_type":"a","external_id":[],"lens_id":[],"sequence":193,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":95,"text":"Apr. 15, 2011 Joint Claim Construction Chart by Cephalon et al. and Sandoz Inc.","npl_type":"a","external_id":[],"lens_id":[],"sequence":194,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":96,"text":"Apr. 14, 2011 Sealed Answering Brief in Opposition re: 88 Motion to Stay Plaintiff's Motion to Stay Proceedings filed by Sandoz Inc. (Attchmnts: # 1 Exh 1-15).","npl_type":"a","external_id":[],"lens_id":[],"sequence":195,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":97,"text":"Apr. 11, 2011 Ceph et al. v. Sandoz Fifth Stipulated Amendment to Scheduling Order.","npl_type":"a","external_id":[],"lens_id":[],"sequence":196,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":98,"text":"Apr. 11, 2011 Ceph et al. v. Mylan et al., Order for Scheduling Conference.","npl_type":"a","external_id":[],"lens_id":[],"sequence":197,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":99,"text":"Apr. 5, 2011 Redacted Version of 96 Letter, to Judge Thynge from Poff regarding Sandoz opposing an extension of pretrial dates requested by Ceph. (ltr dated Mar. 29, 2011).","npl_type":"a","external_id":[],"lens_id":[],"sequence":198,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}}],"reference_cited.source":"DOCDB","reference_cited.patent_count":102,"cites_patent":true,"reference_cited.npl_count":99,"reference_cited.npl_resolved_count":30,"cites_npl":true,"cites_resolved_npl":true,"cited_by":{"patent_count":2,"patent":[{"lens_id":"092-124-172-129-161","document_id":{"jurisdiction":"AU","doc_number":"2019362348","kind":"B2"}},{"lens_id":"082-895-865-537-769","document_id":{"jurisdiction":"US","doc_number":"9919007","kind":"B2"}}]},"cited_by_patent":true,"family":{"simple":{"size":8,"id":185029205,"member":[{"lens_id":"080-202-844-883-171","document_id":{"jurisdiction":"US","doc_number":"8753611","kind":"B2","date":"2014-06-17"}},{"lens_id":"005-623-340-334-377","document_id":{"jurisdiction":"US","doc_number":"20110223115","kind":"A1","date":"2011-09-15"}},{"lens_id":"018-300-682-310-100","document_id":{"jurisdiction":"US","doc_number":"20020110578","kind":"A1","date":"2002-08-15"}},{"lens_id":"115-830-050-567-13X","document_id":{"jurisdiction":"US","doc_number":"6974590","kind":"B2","date":"2005-12-13"}},{"lens_id":"039-515-711-342-997","document_id":{"jurisdiction":"US","doc_number":"8728441","kind":"B2","date":"2014-05-20"}},{"lens_id":"080-526-583-796-272","document_id":{"jurisdiction":"US","doc_number":"8765100","kind":"B2","date":"2014-07-01"}},{"lens_id":"140-020-966-134-942","document_id":{"jurisdiction":"US","doc_number":"20090202632","kind":"A1","date":"2009-08-13"}},{"lens_id":"130-134-119-633-065","document_id":{"jurisdiction":"US","doc_number":"20110212034","kind":"A1","date":"2011-09-01"}}]},"extended":{"size":72,"id":185018596,"member":[{"lens_id":"080-586-344-016-210","document_id":{"jurisdiction":"JP","doc_number":"4789324","kind":"B2","date":"2011-10-12"}},{"lens_id":"151-173-009-171-828","document_id":{"jurisdiction":"CA","doc_number":"2335566","kind":"A1","date":"2000-11-09"}},{"lens_id":"032-250-097-433-454","document_id":{"jurisdiction":"PT","doc_number":"1417959","kind":"E","date":"2009-07-02"}},{"lens_id":"039-515-711-342-997","document_id":{"jurisdiction":"US","doc_number":"8728441","kind":"B2","date":"2014-05-20"}},{"lens_id":"196-183-242-971-508","document_id":{"jurisdiction":"US","doc_number":"20030133976","kind":"A1","date":"2003-07-17"}},{"lens_id":"197-248-071-891-845","document_id":{"jurisdiction":"ES","doc_number":"2383478","kind":"T3","date":"2012-06-21"}},{"lens_id":"177-170-537-125-980","document_id":{"jurisdiction":"US","doc_number":"6641838","kind":"B2","date":"2003-11-04"}},{"lens_id":"099-927-519-597-110","document_id":{"jurisdiction":"US","doc_number":"20050037072","kind":"A1","date":"2005-02-17"}},{"lens_id":"061-010-251-632-419","document_id":{"jurisdiction":"EP","doc_number":"2095813","kind":"A1","date":"2009-09-02"}},{"lens_id":"084-646-750-468-447","document_id":{"jurisdiction":"US","doc_number":"20020076439","kind":"A1","date":"2002-06-20"}},{"lens_id":"090-607-545-682-896","document_id":{"jurisdiction":"US","doc_number":"20050064030","kind":"A1","date":"2005-03-24"}},{"lens_id":"163-690-147-670-001","document_id":{"jurisdiction":"JP","doc_number":"2009029829","kind":"A","date":"2009-02-12"}},{"lens_id":"170-043-442-735-691","document_id":{"jurisdiction":"US","doc_number":"6509036","kind":"B2","date":"2003-01-21"}},{"lens_id":"089-490-021-007-644","document_id":{"jurisdiction":"AT","doc_number":"E433745","kind":"T1","date":"2009-07-15"}},{"lens_id":"006-541-295-719-725","document_id":{"jurisdiction":"PT","doc_number":"1082106","kind":"E","date":"2007-02-28"}},{"lens_id":"084-982-921-379-549","document_id":{"jurisdiction":"PT","doc_number":"1419765","kind":"E","date":"2009-07-02"}},{"lens_id":"010-489-412-424-635","document_id":{"jurisdiction":"DE","doc_number":"60032691","kind":"T2","date":"2007-10-18"}},{"lens_id":"192-710-482-789-402","document_id":{"jurisdiction":"US","doc_number":"20020071809","kind":"A1","date":"2002-06-13"}},{"lens_id":"101-693-721-062-057","document_id":{"jurisdiction":"EP","doc_number":"1417959","kind":"B1","date":"2009-06-17"}},{"lens_id":"001-787-317-934-388","document_id":{"jurisdiction":"CY","doc_number":"1109172","kind":"T1","date":"2014-07-02"}},{"lens_id":"153-818-756-845-978","document_id":{"jurisdiction":"DK","doc_number":"1419765","kind":"T3","date":"2009-07-20"}},{"lens_id":"018-114-125-260-260","document_id":{"jurisdiction":"WO","doc_number":"2000066089","kind":"A1","date":"2000-11-09"}},{"lens_id":"007-126-200-943-133","document_id":{"jurisdiction":"AU","doc_number":"4488700","kind":"A","date":"2000-11-17"}},{"lens_id":"034-182-019-705-46X","document_id":{"jurisdiction":"CA","doc_number":"2335566","kind":"C","date":"2010-07-06"}},{"lens_id":"046-531-862-011-849","document_id":{"jurisdiction":"EP","doc_number":"1082106","kind":"A1","date":"2001-03-14"}},{"lens_id":"184-002-458-262-857","document_id":{"jurisdiction":"CA","doc_number":"2333375","kind":"C","date":"2007-05-29"}},{"lens_id":"132-586-219-193-175","document_id":{"jurisdiction":"US","doc_number":"20060292219","kind":"A1","date":"2006-12-28"}},{"lens_id":"003-527-935-227-156","document_id":{"jurisdiction":"AU","doc_number":"4019400","kind":"A","date":"2000-10-16"}},{"lens_id":"124-940-213-080-603","document_id":{"jurisdiction":"DK","doc_number":"1082106","kind":"T3","date":"2007-04-10"}},{"lens_id":"044-945-129-100-133","document_id":{"jurisdiction":"US","doc_number":"6391335","kind":"B1","date":"2002-05-21"}},{"lens_id":"156-675-482-451-827","document_id":{"jurisdiction":"US","doc_number":"6576250","kind":"B1","date":"2003-06-10"}},{"lens_id":"060-807-801-807-343","document_id":{"jurisdiction":"JP","doc_number":"2002543109","kind":"A","date":"2002-12-17"}},{"lens_id":"183-562-603-603-187","document_id":{"jurisdiction":"ES","doc_number":"2276677","kind":"T3","date":"2007-07-01"}},{"lens_id":"051-885-027-812-633","document_id":{"jurisdiction":"JP","doc_number":"2002540141","kind":"A","date":"2002-11-26"}},{"lens_id":"018-300-682-310-100","document_id":{"jurisdiction":"US","doc_number":"20020110578","kind":"A1","date":"2002-08-15"}},{"lens_id":"026-423-878-600-10X","document_id":{"jurisdiction":"CY","doc_number":"1109176","kind":"T1","date":"2014-07-02"}},{"lens_id":"062-339-947-677-199","document_id":{"jurisdiction":"CY","doc_number":"1107592","kind":"T1","date":"2013-03-13"}},{"lens_id":"046-898-004-007-043","document_id":{"jurisdiction":"US","doc_number":"20030118645","kind":"A1","date":"2003-06-26"}},{"lens_id":"184-675-423-418-723","document_id":{"jurisdiction":"US","doc_number":"6350470","kind":"B1","date":"2002-02-26"}},{"lens_id":"056-173-009-240-957","document_id":{"jurisdiction":"DK","doc_number":"1417959","kind":"T3","date":"2009-07-27"}},{"lens_id":"101-405-113-117-836","document_id":{"jurisdiction":"EP","doc_number":"1419765","kind":"A1","date":"2004-05-19"}},{"lens_id":"007-699-000-283-140","document_id":{"jurisdiction":"EP","doc_number":"1417959","kind":"A1","date":"2004-05-12"}},{"lens_id":"194-153-800-796-936","document_id":{"jurisdiction":"CA","doc_number":"2333375","kind":"A1","date":"2000-10-05"}},{"lens_id":"115-830-050-567-13X","document_id":{"jurisdiction":"US","doc_number":"6974590","kind":"B2","date":"2005-12-13"}},{"lens_id":"163-251-268-477-051","document_id":{"jurisdiction":"CA","doc_number":"2569674","kind":"C","date":"2011-11-08"}},{"lens_id":"140-020-966-134-942","document_id":{"jurisdiction":"US","doc_number":"20090202632","kind":"A1","date":"2009-08-13"}},{"lens_id":"029-064-372-755-259","document_id":{"jurisdiction":"US","doc_number":"8802130","kind":"B2","date":"2014-08-12"}},{"lens_id":"178-778-123-375-869","document_id":{"jurisdiction":"US","doc_number":"20030091629","kind":"A1","date":"2003-05-15"}},{"lens_id":"080-526-583-796-272","document_id":{"jurisdiction":"US","doc_number":"8765100","kind":"B2","date":"2014-07-01"}},{"lens_id":"048-341-753-345-036","document_id":{"jurisdiction":"DE","doc_number":"60042463","kind":"D1","date":"2009-08-06"}},{"lens_id":"057-464-866-174-479","document_id":{"jurisdiction":"EP","doc_number":"2095813","kind":"B1","date":"2012-03-07"}},{"lens_id":"082-872-907-517-255","document_id":{"jurisdiction":"US","doc_number":"6200604","kind":"B1","date":"2001-03-13"}},{"lens_id":"004-829-236-624-128","document_id":{"jurisdiction":"EP","doc_number":"1091732","kind":"A1","date":"2001-04-18"}},{"lens_id":"008-797-724-509-93X","document_id":{"jurisdiction":"JP","doc_number":"4954170","kind":"B2","date":"2012-06-13"}},{"lens_id":"059-444-413-538-801","document_id":{"jurisdiction":"AT","doc_number":"E548028","kind":"T1","date":"2012-03-15"}},{"lens_id":"095-385-715-930-997","document_id":{"jurisdiction":"CA","doc_number":"2569674","kind":"A1","date":"2000-10-05"}},{"lens_id":"076-426-623-946-392","document_id":{"jurisdiction":"WO","doc_number":"2000057858","kind":"A1","date":"2000-10-05"}},{"lens_id":"117-385-477-403-10X","document_id":{"jurisdiction":"DE","doc_number":"60032691","kind":"D1","date":"2007-02-15"}},{"lens_id":"080-202-844-883-171","document_id":{"jurisdiction":"US","doc_number":"8753611","kind":"B2","date":"2014-06-17"}},{"lens_id":"031-664-440-325-578","document_id":{"jurisdiction":"ES","doc_number":"2324908","kind":"T3","date":"2009-08-19"}},{"lens_id":"179-463-747-417-254","document_id":{"jurisdiction":"US","doc_number":"6764696","kind":"B2","date":"2004-07-20"}},{"lens_id":"176-957-805-922-015","document_id":{"jurisdiction":"AT","doc_number":"E434432","kind":"T1","date":"2009-07-15"}},{"lens_id":"105-518-275-194-961","document_id":{"jurisdiction":"AT","doc_number":"E350017","kind":"T1","date":"2007-01-15"}},{"lens_id":"005-623-340-334-377","document_id":{"jurisdiction":"US","doc_number":"20110223115","kind":"A1","date":"2011-09-15"}},{"lens_id":"130-134-119-633-065","document_id":{"jurisdiction":"US","doc_number":"20110212034","kind":"A1","date":"2011-09-01"}},{"lens_id":"072-825-383-284-07X","document_id":{"jurisdiction":"ES","doc_number":"2324907","kind":"T3","date":"2009-08-19"}},{"lens_id":"058-281-886-854-732","document_id":{"jurisdiction":"EP","doc_number":"1419765","kind":"B1","date":"2009-06-24"}},{"lens_id":"183-871-347-752-739","document_id":{"jurisdiction":"EP","doc_number":"1082106","kind":"B1","date":"2007-01-03"}},{"lens_id":"121-324-244-264-255","document_id":{"jurisdiction":"HK","doc_number":"1130691","kind":"A1","date":"2010-01-08"}},{"lens_id":"002-924-456-233-375","document_id":{"jurisdiction":"DE","doc_number":"60042427","kind":"D1","date":"2009-07-30"}},{"lens_id":"132-731-008-681-871","document_id":{"jurisdiction":"EP","doc_number":"1082106","kind":"A4","date":"2002-07-03"}},{"lens_id":"106-937-531-060-691","document_id":{"jurisdiction":"EP","doc_number":"1091732","kind":"A4","date":"2006-01-18"}}]}},"has_sequence":false,"legal_status":{"ipr_type":"patent for invention","granted":true,"earliest_filing_date":"1999-03-26","grant_date":"2014-06-17","anticipated_term_date":"2019-03-26","discontinuation_date":"2022-07-25","has_disclaimer":true,"patent_status":"EXPIRED","publication_count":2,"has_spc":false,"has_grant_event":true,"has_entry_into_national_phase":false},"abstract":{"en":[{"text":"A pharmaceutical dosage form adapted to supply a medicament to the oral cavity for buccal, sublingual or gingival absorption of the medicament which contains an orally administrable medicament in combination with an effervescent for use in promoting absorption of the medicament in the oral cavity. The use of an additional pH adjusting substance in combination with the effervescent for promoting the absorption drugs is also disclosed.","lang":"en","source":"USPTO_FULLTEXT","data_format":"ORIGINAL"}]},"abstract_lang":["en"],"has_abstract":true,"claim":{"en":[{"text":"1. A method of administering at least one systemically distributable pharmaceutical agent across the oral mucosa comprising: a) providing a solid oral dosage form including: (1) an orally administerable medicament that is present in an amount that is pharmaceutically effective for buccal mucosal, gingival, or sublingual mucosal administration; (2) at least one pH adjusting substance, which is a base selected from sodium carbonate, potassium carbonate, magnesium carbonate, disodium hydrogen phosphate, sodium dihydrogen phosphate, dipotassium hydrogen phosphate, and potassium dihydrogen phosphate; and (3) at least one saliva activated effervescent couple in an amount sufficient to increase absorption of said orally administerable medicament across the oral mucosa, wherein said effervescent couple comprises an acid selected from citric, tartaric, malic, fumaric, adipic and succinic acid, and a base selected from sodium bicarbonate, sodium carbonate, potassium bicarbonate, potassium carbonate, and magnesium carbonate; wherein said orally administerable medicament is not substantially encompassed by or dispersed in a material that prevents absorption of said medicament across the oral mucosa; b) placing said solid oral dosage form in the mouth of a patient so that saliva in said patient's mouth activates said at least one effervescent couple in said tablet; and c) holding said solid oral dosage form and dissolving the contents of said solid oral dosage form in the mouth of a patient whereby said at least one effervescent couple promotes absorption of said orally administerable medicament across the oral mucosa.","lang":"en","source":"USPTO_FULLTEXT","data_format":"ORIGINAL"},{"text":"2. The method of administering at least one systemically distributable pharmaceutical agent according to claim 1 wherein said step c) includes holding said solid oral dosage form and dissolving the contents of said solid oral dosage form in said mouth adjacent a cheek for buccal administration.","lang":"en","source":"USPTO_FULLTEXT","data_format":"ORIGINAL"},{"text":"3. The method of administering at least one systemically distributable pharmaceutical agent according to claim 1 wherein said step c) includes holding said solid oral dosage form and dissolving the contents of said solid oral dosage form in said mouth beneath the tongue for sublingual administration.","lang":"en","source":"USPTO_FULLTEXT","data_format":"ORIGINAL"},{"text":"4. The method of administering at least one systemically distributable pharmaceutical agent according to claim 1 wherein said step c) includes holding said solid oral dosage form and dissolving the contents of said solid oral dosage form in said mouth between the upper lip and gum for gingival administration.","lang":"en","source":"USPTO_FULLTEXT","data_format":"ORIGINAL"},{"text":"5. The method of administering at least one systemically distributable pharmaceutical agent according to claim 1 , wherein said solid oral dosage form further includes a bioadhesive, wherein said bioadhesive increases the contact time between said solid oral dosage form and the oral mucosa.","lang":"en","source":"USPTO_FULLTEXT","data_format":"ORIGINAL"},{"text":"6. The method of administering at least one systemically distributable pharmaceutical agent according to claim 1 , wherein said solid oral dosage form further includes glidants, lubricants, binders, sweeteners, flavoring and coloring components.","lang":"en","source":"USPTO_FULLTEXT","data_format":"ORIGINAL"},{"text":"7. The method of administering at least one systemically distributable pharmaceutical agent according to claim 1 , wherein said orally administerable medicament is selected from the group consisting of analgesics, anti-inflammatories, antipyretics, antibiotics, antimicrobials, laxatives, anorexics, antihistamines, antiasthmatics, antidiuretics, antiflatuents, anti-emetics, antimigraine agents, antispasmodics, sedatives, antihyperactives, antihypertensives, tranquilizers, decongestants, and beta blockers.","lang":"en","source":"USPTO_FULLTEXT","data_format":"ORIGINAL"},{"text":"8. The method of administering at least one systemically distributable pharmaceutical agent according to claim 1 , wherein said orally administerable medicament is selected from the group consisting of peptides, proteins and oligonucleotides.","lang":"en","source":"USPTO_FULLTEXT","data_format":"ORIGINAL"},{"text":"9. The method of administering at least one systemically distributable pharmaceutical agent according to claim 1 , wherein said at least one effervescent couple is present in an amount between about 5% by weight and 95% by weight.","lang":"en","source":"USPTO_FULLTEXT","data_format":"ORIGINAL"},{"text":"10. The method of administering at least one systemically distributable pharmaceutical agent according to claim 1 , wherein said at least one effervescent couple is present in an amount between about 30% by weight and 80% by weight.","lang":"en","source":"USPTO_FULLTEXT","data_format":"ORIGINAL"},{"text":"11. The method of administering at least one systemically distributable pharmaceutical agent according to claim 1 , wherein said at least one effervescent couple is present in an amount sufficient to evolve a gas in an amount between about 5 cm to about 30 cm.","lang":"en","source":"USPTO_FULLTEXT","data_format":"ORIGINAL"}]},"claim_lang":["en"],"has_claim":true,"description":{"en":{"text":"CROSS-REFERENCE TO RELATED APPLICATION The present application is a Continuation Application of U.S. patent application Ser. No. 12/429,475, filed Apr. 24, 2009, which is a Continuation of U.S. patent application Ser. No. 09/661,693, filed Sep. 14, 2000, now abandoned, which is a Continuation Application of U.S. patent application Ser. No. 09/327,814 filed Jun. 8, 1999, now patented as U.S. Pat. No. 6,200,604, which is a Continuation Application of U.S. patent application Ser. No. 09/277,424, filed Mar. 26, 1999, now abandoned, which claims the benefit of U.S. Provisional Application No. 60/079,652 filed on Mar. 27, 1998, now expired, the disclosures of which are herein incorporated by reference in their entirety. The present application is also related to U.S. Pat. No. 6,974,590, U.S. patent application Ser. No. 10/269,669, filed Oct. 11, 2002, U.S. patent application Ser. No. 10/977,029 filed Oct. 29, 2004 and U.S. patent application Ser. No. 11/511,098, filed Aug. 28, 2006, the disclosures of which are herein incorporated by reference. FIELD OF THE INVENTION The present invention relates to pharmaceutical compositions, and more particularly to pharmaceutical compositions for oral administration of a medicament, which contain an effervescent agent for enhancing oral drug absorption across the buccal, sublingual, and gingival mucosa. DESCRIPTION OF PRIOR ART Effervescents have been shown to be useful and advantageous for oral administration. See Pharmaceutical Dosage Forms: Tablets Volume I, Second Edition. A. Lieberman. ed. 1989, Marcel Dekker, Inc. As discussed in this text, and as commonly employed, an effervescent tablet is dissolved in water to provide a carbonated or sparkling liquid drink. See also U.S. Pat. Nos. 5,102,665 and 5,468,504 to Schaeffer, herein incorporated by reference. In such a drink, the effervescent helps to mask the taste of medicaments. Effervescent compositions have also been employed for use as taste masking agents in dosage forms which are not dissolved in water prior to administration. For example, U.S. Pat. No. 4,639,368 describes a chewing gum containing a medicament capable of absorption through the buccal cavity and containing a taste masking amount of an effervescent. More recently effervescents have been employed to obtain rapid dissolution and/or dispersion of the medicament in the oral cavity. See U.S. Pat. Nos. 5,178,878 and 5,223,264. The effervescent tends to stimulate saliva production thereby providing additional water to aid in further effervescent to a faster onset of action and/or improved bioavailability action. These dosage forms give an agreeable presentation of the drug, particularly for patients who have difficulty in swallowing tablets or capsules. PCT application WO 97/06786 describes pre-gastric absorption of certain drugs using rapidly-disbursing dosage forms. Various proposals have been advanced for oral mucosal administration of various drugs. When drugs are absorbed from the oral mucosa, they bypass the gastrointestinal and hepatic metabolism process. This can lead of a drug. However, many compounds do not rapidly penetrate the oral mucosa. See, e.g., Christina Graffner, Clinical Experience with Novel Buccal and Sublingual Administration; NOVEL DRUG DELIVERY AND ITS THERAPEUTIC APPLICATION, edited by L. F. Prescott and W. S. Nimmo (1989); David Harris & Joseph R. Robinson, Drug Delivery via the Mucous Membranes of the Oral Cavity; JOURNAL OF PHARMACEUTICAL SCIENCES, Vol. 81 (January 1992); Oral Mucosal Delivery, edited by M. J. Rathbone, which are herein incorporated by reference. The compounds which may be well absorbed per-orally (through the gastrointestinal tract) may not be well absorbed through the mucosa of the mouth because the oral mucosa is less permeable than the intestinal mucosa and it does not offer as big a surface area as the small intestine. Despite these and other efforts toward increasing the permeation of medicaments across the oral mucosa, there have been unmet needs for improved methods of administrating medicaments across the oral mucosa. SUMMARY OF THE INVENTION The pharmaceutical compositions of the present invention comprise an orally administrable medicament in combination with an effervescent agent used as penetration enhancer to influence the permeability of the medicament across the buccal, sublingual, and gingival mucosa. DETAILED DESCRIPTION OF THE INVENTION One aspect of this invention is to use effervescent as penetration enhancers for influencing oral drug absorption. Effervescent agents can be used alone or in combination with other penetration enhancers, which leads to an increase in the rate and extent of absorption of an active drug. It is believed that such increase can rise from one or all of the following mechanisms: 1. reducing the mucosal layer thickness and/or viscosity; 2. tight junction alteration; 3. inducing a change in the cell membrane structure; and 4. increasing the hydrophobic environment within the cellular membrane. The present dosage forms should include an amount of an effervescent agent effective to aid in penetration of the drug across the oral mucosa. Preferably, the effervescent is provided in an amount of between about 5% and about 95% by weight, based on the weight of the finished tablet, and more preferably in an amount of between about 30% and about 80% by weight. It is particularly preferred that sufficient effervescent material be provided such that the evolved gas is more than about 5 cm.sup.3 but less than about 30 cm.sup.3, upon exposure of the tablet to an aqueous environment. However, the amount of effervescent agent must be optimized for each specific drug. The term “effervescent agent” includes compounds which evolve gas. The preferred effervescent agents evolve gas by means of a chemical reaction which takes place upon exposure of the effervescent agent (an effervescent couple) to water and/or to saliva in the mouth. This reaction is most often the result of the reaction of a soluble acid source and a source of carbon dioxide such as an alkaline carbonate or bicarbonate. The reaction of these two general compounds produces carbon dioxide gas upon contact with water or saliva. Such water-activated materials must be kept in a generally anhydrous state and with little or no absorbed moisture or in a stable hydrated form, since exposure to water will prematurely disintegrate the tablet. The acid sources may be any which are safe for human consumption and may generally include food acids, acid and hydrite antacids such as, for example: citric, tartaric, amalic, fumeric, adipic, and succinics. Carbonate sources include dry solid carbonate and bicarbonate salt such as, preferably, sodium bicarbonate, sodium carbonate, potassium bicarbonate and potassium carbonate, magnesium carbonate and the like. Reactants which evolve oxygen or other gasses and which are safe for human consumption are also included. The effervescent agent(s) of the present invention is not always based upon reaction which forms carbon dioxide. Reactants which evolve oxygen or other gasses which are safe for human consumption are also considered within the scope. Where the effervescent agent includes two mutually reactive components, such as an acid source and a carbonate source, it is preferred that both components react completely. Therefore, an equivalent ratio of components which provides for equal equivalents is preferred. For example, if the acid used is diprotic, then either twice the amount of a mono-reactive carbonate base, or an equal amount of a di-reactive base should be used for complete neutralization to be realized. However, in other embodiments of the present invention, the amount of either acid or carbonate source may exceed the amount of the other component. This may be useful to enhance taste and/or performance of a tablet containing an overage of either component. In this case, it is acceptable that the additional amount of either component may remain unreacted. The present dosage forms may also include in amounts additional to that required for effervescence a pH adjusting substance. For drugs that are weakly acidic or weakly basic, the pH of the aqueous environment can influence the relative concentrations of the ionized and unionized forms of the drug present in solution according to the Henderson-Hasselbach equation. The pH solutions in which an effervescent couple has dissolved is slightly acidic due to the evolution of carbon dioxide. The pH of the local environment, e.g., saliva in immediate contact with the tablet and any drug that may have dissolved from it, may be adjusted by incorporating in the tablet a pH adjusting substances which permit the relative portions of the ionized and unionized forms of the drug to be controlled. In this way, the present dosage forms can be optimized for each specific drug. If the unionized drug is known or suspected to be absorbed through the cell membrane (transcellular absorption) it would be preferable to alter the pH of the local environment (within the limits tolerable to the subject) to a level that favors the unionized form of the drug. Conversely, if the ionized form is more readily dissolved the local environment should favor ionization. The aqueous solubility of the drug should preferably not be compromised by the effervescent and pH adjusting substance, such that the dosage forms permit a sufficient concentration of the drug to be present in the unionized form. The percentage of the pH adjusting substance and/or effervescent should therefore be adjusted depending on the drug. Suitable pH adjusting substance for use in the present invention include any weak acid or weak base in amounts additional to that required for the effervescence or, preferably, any buffer system that is not harmful to the oral mucosa. Suitable pH adjusting substance for use in the present invention include, but are not limited to, any of the acids or bases previously mentioned as effervescent compounds, disodium hydrogen phosphate, sodium dihydrogen phosphate and the equivalent potassium salt. The active ingredient suitable for use in the present dosage forms can include systematically distributable pharmaceutical ingredients, vitamins, minerals, dietary supplements, as well as non-systematically distributable drugs. Preferably, the active ingredient is a systemically active pharmaceutical ingredient which is absorbable by the body through the oral mucosa. Although the dosage forms can be employed with a wide range of drugs, as discussed below, it is especially suitable for drugs and other pharmaceutical ingredients which suffer significant loss of activity in the lumen of the gastrointestinal tract or in the tissues of the gastrointestinal tract during absorption process or upon passage through the liver after absorption in the intestinal tract. Absorption through the oral mucosa allows the drug to enter the systemic circulation without first passing through the liver, and thus alleviates the loss of activity upon passage through the liver. Pharmaceutical ingredients may include, without limitation, analgesics, anti-inflammatories, antipyretics, antibiotics, antimicrobials, laxatives, anorexics, antihistamines, antiasthmatics, antidiuretics, antiflatulents, antimigraine agents, antispasmodics, sedatives, antihyperactives, antihypertensives, tranquilizers, decongestants, beta blockers; peptides, proteins, oligonucleotides and other substances of biological origin, and combinations thereof. Also encompassed by the terms “active ingredient(s)”, “pharmaceutical ingredient(s)” and “active agents” are the drugs and pharmaceutically active ingredients described in Mantelle, U.S. Pat. No. 5,234,957, in columns 18 through 21. That text of Mantelle is hereby incorporated by reference. Alternatively or additionally, the active ingredient can include drugs and other pharmaceutical ingredients, vitamins, minerals and dietary supplements as the same are defined in U.S. Pat. No. 5,178,878, the disclosure of which is also incorporated by reference herein. The dosage form preferably includes an effervescent couple, in combination with the other ingredients to enhance the absorption of the pharmaceutical ingredient across the oral mucosa and to improve the disintegration profile and the organoleptic properties of the dosage form. For example, the area of contact between the dosage form and the oral mucosa, and the residence time of the dosage form in the oral cavity can be improved by including a bioadhesive polymer in this drug delivery system. See, e.g., Mechanistic Studies on Effervescent-Induced Permeability Enhancement by Jonathan Eichman (1997), which is incorporated by reference herein. Effervescence, due to its mucus stripping properties, would also enhance the residence time of the bioadhesive, thereby increasing the residence time for the drug absorption. Non-limiting examples of bioadhesives used in the present invention include, for example, Carbopol 934 P, Na CMC, Methocel, Polycarbophil (Noveon AA-1), HPMC, Na alginate, Na Hyaluronate and other natural or synthetic bioadhesives. In addition to the effervescence-producing agents, a dosage form according to the present invention may also include suitable non-effervescent disintegration agents. Non-limiting examples of non-effervescent disintegration agents include: microcrystalline, cellulose, croscarmellose sodium, crospovidone, starches, corn starch, potato starch and modified starches thereof, sweeteners, clays, such as bentonite, alginates, gums such as agar, guar, locust bean, karaya, pecitin and tragacanth. Disintegrants may comprise up to about 20 weight percent and preferably between about 2 and about 10% of the total weight of the composition. In addition to the particles in accordance with the present invention, the dosage forms may also include glidants, lubricants, binders, sweeteners, flavoring and coloring components. Any conventional sweetener or flavoring component may be used. Combinations of sweeteners, flavoring components, or sweeteners and flavoring components may likewise be used. Examples of binders which can be used include acacia, tragacanth, gelatin, starch, cellulose materials such as methyl cellulose and sodium carboxy methyl cellulose, alginic acids and salts thereof, magnesium aluminum silicate, polyethylene glycol, guar gum, polysaccharide acids, bentonites, sugars, invert sugars and the like. Binders may be used in an amount of up to 60 weight percent and preferably about 10 to about 40 weight percent of the total composition. Coloring agents may include titanium dioxide, and dyes suitable for food such as those known as FD&C dyes and natural coloring agents such as grape skin extract, beet red powder, beta-carotene, annato, carmine, turmeric, paprika, etc. The amount of coloring used may range from about 0.1 to about 3.5 weight percent of the total composition. Flavors incorporated in the composition may be chosen from synthetic flavor oils and flavoring aromatics and/or natural oils, extracts from plants, leaves, flowers, fruits and so forth and combinations thereof. These may include cinnamon oil, oil of wintergreen, peppermint oils, clove oil, bay oil, anise oil, eucalyptus, thyme oil, cedar leave oil, oil of nutmeg, oil of sage, oil of bitter almonds and cassia oil. Also useful as flavors are vanilla, citrus oil, including lemon, orange, grape, lime and grapefruit, and fruit essences, including apple, pear, peach, strawberry, raspberry, cherry, plum, pineapple, apricot and so forth. Flavors which have been found to be particularly useful include commercially available orange, grape, cherry and bubble gum flavors and mixtures thereof. The amount of flavoring may depend on a number of factors, including the organoleptic effect desired. Flavors may be present in an amount ranging from about 0.05 to about 3 percent by weight based upon the weight of the composition. Particularly preferred flavors are the grape and cherry flavors and citrus flavors such as orange. One aspect of the invention provides a solid, oral tablet dosage form suitable for sublingual, buccal, and gingival administration. Excipient fillers can be used to facilitate tableting. The filler desirably will also assist in the rapid dissolution of the dosage form in the mouth. Non-limiting examples of suitable fillers include: mannitol, dextrose, lactose, sucrose, and calcium carbonate. Method of Manufacture Tablets can either be manufactured by direct compression, wet granulation or any other tablet manufacturing technique. See, e.g., U.S. Pat. Nos. 5,178,878 and 5,223,264, which are incorporated by reference herein. The tablet may be a layered tablet consisting of a layer of the active ingredient sandwiched between a bioadhesive layer and an effervescence layer. Other layered forms which include the ingredients set forth above in layers of diverse compositions. Effervescence Level: Between 5%-95%Tablet size: Between 3/16″-⅝″Tablet hardness: Between 5N and 80NRoute of administration: Sublingual, Buccal, Gingival The dosage form may be administered to a human or other mammalian subject by placing the dosage form in the subject's mouth and holding it in the mouth, either adjacent a cheek (for buccal administration), beneath the tongue (for sublingual administration) and between the upper lip and gum (for gingival administration). The dosage form spontaneously begins to disintegrate due to the moisture in the mouth. The disintegration, and particularly the effervescence, stimulates additional salivation which further enhances disintegration. Example 1 The dosage form should include Fentanyl, an effervescent and pH adjusting substance so that the pH is adjusted to neutral (or slightly higher) since the pKa of fentanyl is 7.3. At this pH, the aqueous solubility of this poorly water-soluble drug would not be compromised unduly, and would permit a sufficient concentration of the drug to be present in the unionized form. Two fentanyl formulations, each containing 36% effervescence, were produced. These tablets were compressed using half-inch shallow concave punches. FORMULATIONCOMPONENTQUANTITY (MGSHORTFentanyl, citrate, USP1.57DISINTEGRATIONLactose monohydrate119.47TIMEMicrocrystallineCellulose,119.47SilicifiedSodium bicarbonate46.99anhydrousCitric acid, anhydrous105Polyvinylphrrolidone,75cross-linkedMagnesium stearate25Colloidal silicon dioxide2.5Total tablet mass500Fentanyl citrate, USP1.57LONGLactose Monohydrate270.93DISINTEGRATIONSodium carbonate,40.00anhydrousTIMESodium bicarbonate105Citric acid, anhydrous75Magnesium stearate5Colloidal silicon dioxide2.5Total tablet mass500 The dosage form included prochlorperazine (pKa=8.1), an effervescent and pH adjusting substance so that a slightly higher pH is produced to facilitate the permeation enhancement. With respect to prochlorperazine, an anti-emetic drug, two formulations, buccal and sublingual, were developed. The buccal tablets were compressed as quarter inch diameter biconvex tablets, whereas the sublingual tablets were three-eighths inch diameter biconvex tablets. These dimensions were chosen to give a comfortable fit in the respective part of the oral cavity for which they were designed. The formulae for these tablets are as follows: Example 2 FORMULATIONCOMPONENT NAMEQUANTITY (MG)BUCCALPhrochlorperazine5.00Sodium Bicarbonate15.52Citric Acid, Anhydrous11.08Sodium Bicarbonate45.78HPMCK4M Prem5.00Dicalcium phosphate5.00dihydrateMannitol11.67Magnesium Stearate0.95TOTAL100.00SUBLINGUALPhrochlorperazine5.00Sodium Bicarbonate61.25Citric Acid, Anhydrous43.75Sodium Bicarbonate95Sodium carbonate91.25HPMC Methocel K4M40PremMannitol60Magnesium Stearate3.75TOTAL400","lang":"en","source":"USPTO_FULLTEXT","data_format":"ORIGINAL"}},"description_lang":["en"],"has_description":true,"has_docdb":true,"has_inpadoc":true,"has_full_text":true,"biblio_lang":"en"},"jurisdiction":"US","collections":[],"usersTags":[],"lensId":"080-202-844-883-171","publicationKey":"US_8753611_B2","displayKey":"US 8753611 B2","docAssets":{"lensId":"080-202-844-883-171","pdfUrl":"https://www.lens.org/images/patent/US/8753611/B2/US_8753611_B2.pdf","images":[{"thumb":"https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/8753/8753611/image/page/10pc/00000001.png","full":"https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/8753/8753611/image/page/full/00000001.png"},{"thumb":"https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/8753/8753611/image/page/10pc/00000002.png","full":"https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/8753/8753611/image/page/full/00000002.png"},{"thumb":"https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/8753/8753611/image/page/10pc/00000003.png","full":"https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/8753/8753611/image/page/full/00000003.png"},{"thumb":"https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/8753/8753611/image/page/10pc/00000004.png","full":"https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/8753/8753611/image/page/full/00000004.png"},{"thumb":"https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/8753/8753611/image/page/10pc/00000005.png","full":"https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/8753/8753611/image/page/full/00000005.png"},{"thumb":"https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/8753/8753611/image/page/10pc/00000006.png","full":"https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/8753/8753611/image/page/full/00000006.png"},{"thumb":"https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/8753/8753611/image/page/10pc/00000007.png","full":"https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/8753/8753611/image/page/full/00000007.png"},{"thumb":"https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/8753/8753611/image/page/10pc/00000008.png","full":"https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/8753/8753611/image/page/full/00000008.png"},{"thumb":"https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/8753/8753611/image/page/10pc/00000009.png","full":"https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/8753/8753611/image/page/full/00000009.png"},{"thumb":"https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/8753/8753611/image/page/10pc/00000010.png","full":"https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/8753/8753611/image/page/full/00000010.png"},{"thumb":"https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/8753/8753611/image/page/10pc/00000011.png","full":"https://s3-us-west-2.amazonaws.com/lens-resource/patent/US/B2/8753/8753611/image/page/full/00000011.png"}],"fallover":false},"countryName":"USA","inventorModel":{"inventors":[{"name":{"value":"EICHMAN JONATHAN D","valueNormalised":"Eichman Jonathan D"},"inventorship":null},{"name":{"value":"HONTZ JOHN","valueNormalised":"Hontz John"},"inventorship":null},{"name":{"value":"KHANKARI RAJENDRA K","valueNormalised":"Khankari Rajendra K"},"inventorship":null},{"name":{"value":"PATHER SATHASIVAN INDIRAN","valueNormalised":"Pather Sathasivan Indiran"},"inventorship":null},{"name":{"value":"ROBINSON JOSEPH R","valueNormalised":"Robinson Joseph R"},"inventorship":null}],"inventorships":[],"unmatchedInventorships":[],"activeUserHasInventorship":false},"simpleFamilyId":185029205,"citesPatentCount":102,"countrySpec":{"countryName":"USA","description":"GRANTED PATENT AS SECOND PUBLICATION [FROM 2001 ONWARDS]","rule":"pubdate:AFTER:01-01-2001","docType":"GRANTED_PATENT"},"pageTitle":"US 8753611 B2 - Sublingual buccal effervescent","documentTitle":"Sublingual buccal effervescent"},"claims":{"source":"xml_claims","claims":[{"lines":["A method of administering at least one systemically distributable pharmaceutical agent across the oral mucosa comprising:\n
a) providing a solid oral dosage form including:\n\n(1) an orally administerable medicament that is present in an amount that is pharmaceutically effective for buccal mucosal, gingival, or sublingual mucosal administration;\n(2) at least one pH adjusting substance, which is a base selected from sodium carbonate, potassium carbonate, magnesium carbonate, disodium hydrogen phosphate, sodium dihydrogen phosphate, dipotassium hydrogen phosphate, and potassium dihydrogen phosphate; and\n(3) at least one saliva activated effervescent couple in an amount sufficient to increase absorption of said orally administerable medicament across the oral mucosa, wherein said effervescent couple comprises an acid selected from citric, tartaric, malic, fumaric, adipic and succinic acid, and a base selected from sodium bicarbonate, sodium carbonate, potassium bicarbonate, potassium carbonate, and magnesium carbonate;\nwherein said orally administerable medicament is not substantially encompassed by or dispersed in a material that prevents absorption of said medicament across the oral mucosa;\n
b) placing said solid oral dosage form in the mouth of a patient so that saliva in said patient's mouth activates said at least one effervescent couple in said tablet; and\n
c) holding said solid oral dosage form and dissolving the contents of said solid oral dosage form in the mouth of a patient whereby said at least one effervescent couple promotes absorption of said orally administerable medicament across the oral mucosa."],"number":1,"annotation":false,"claim":true,"title":false},{"lines":["The method of administering at least one systemically distributable pharmaceutical agent according to claim 1 wherein said step c) includes holding said solid oral dosage form and dissolving the contents of said solid oral dosage form in said mouth adjacent a cheek for buccal administration."],"number":2,"annotation":false,"claim":true,"title":false},{"lines":["The method of administering at least one systemically distributable pharmaceutical agent according to claim 1 wherein said step c) includes holding said solid oral dosage form and dissolving the contents of said solid oral dosage form in said mouth beneath the tongue for sublingual administration."],"number":3,"annotation":false,"claim":true,"title":false},{"lines":["The method of administering at least one systemically distributable pharmaceutical agent according to claim 1 wherein said step c) includes holding said solid oral dosage form and dissolving the contents of said solid oral dosage form in said mouth between the upper lip and gum for gingival administration."],"number":4,"annotation":false,"claim":true,"title":false},{"lines":["The method of administering at least one systemically distributable pharmaceutical agent according to claim 1, wherein said solid oral dosage form further includes a bioadhesive, wherein said bioadhesive increases the contact time between said solid oral dosage form and the oral mucosa."],"number":5,"annotation":false,"claim":true,"title":false},{"lines":["The method of administering at least one systemically distributable pharmaceutical agent according to claim 1, wherein said solid oral dosage form further includes glidants, lubricants, binders, sweeteners, flavoring and coloring components."],"number":6,"annotation":false,"claim":true,"title":false},{"lines":["The method of administering at least one systemically distributable pharmaceutical agent according to claim 1, wherein said orally administerable medicament is selected from the group consisting of analgesics, anti-inflammatories, antipyretics, antibiotics, antimicrobials, laxatives, anorexics, antihistamines, antiasthmatics, antidiuretics, antiflatuents, anti-emetics, antimigraine agents, antispasmodics, sedatives, antihyperactives, antihypertensives, tranquilizers, decongestants, and beta blockers."],"number":7,"annotation":false,"claim":true,"title":false},{"lines":["The method of administering at least one systemically distributable pharmaceutical agent according to claim 1, wherein said orally administerable medicament is selected from the group consisting of peptides, proteins and oligonucleotides."],"number":8,"annotation":false,"claim":true,"title":false},{"lines":["The method of administering at least one systemically distributable pharmaceutical agent according to claim 1, wherein said at least one effervescent couple is present in an amount between about 5% by weight and 95% by weight."],"number":9,"annotation":false,"claim":true,"title":false},{"lines":["The method of administering at least one systemically distributable pharmaceutical agent according to claim 1, wherein said at least one effervescent couple is present in an amount between about 30% by weight and 80% by weight."],"number":10,"annotation":false,"claim":true,"title":false},{"lines":["The method of administering at least one systemically distributable pharmaceutical agent according to claim 1, wherein said at least one effervescent couple is present in an amount sufficient to evolve a gas in an amount between about 5 cm to about 30 cm."],"number":11,"annotation":false,"claim":true,"title":false}]}},"filters":{"npl":[],"notNpl":[],"applicant":[],"notApplicant":[],"inventor":[],"notInventor":[],"owner":[],"notOwner":[],"tags":[],"dates":[],"types":[],"notTypes":[],"j":[],"notJ":[],"fj":[],"notFj":[],"classIpcr":[],"notClassIpcr":[],"classNat":[],"notClassNat":[],"classCpc":[],"notClassCpc":[],"so":[],"notSo":[],"sat":[]},"sequenceFilters":{"s":"SEQIDNO","d":"ASCENDING","p":0,"n":10,"sp":[],"si":[],"len":[],"t":[],"loc":[]}}